Download Monday August 25

CARO ASM 2014
Outcomes: Clinical and Professional - Success for our Patients and Ourselves
August 25-28, 2014 – Delta St. John’s, Newfoundland
Working Copy: May 29, 2014
Monday August 25, 2014
Preconference
Resident Refresher Course – Salon B
Facilitator: Shahida Ahmed
Objectives: Upon completion of this refresher course, attendees should be able to:
 review the principles of management of common cancers including lymphomas, skin,
head and neck region, bladder , prostate and cervical cancer with emphasis on radiation
treatment planning.
 learn the impact of advancement in imaging, image guidance and cone beam in radiation
treatment planning.
7:15-7:45
Registration and Breakfast – Salon A
7:45-8:00
Welcome and Introductions
8:00-8:50
Skin Cancer
Alia Norman
8:50-9:40
Lymphoma
Jonathan Greenland
9:40-10:00
Break
10:00-10:50
Head and Neck Cancer
Craig Pochini
10:50-11:40
Cervix Cancer
Brent Tompkins
11:40-12:30
lunch
12:30-1:20
Bladder Cancer
Jinka Sathya
1:20-2:10
Prostate Cancer
John Thoms
2:10-2:30
Close
2:30-4:00
Canadian Brachytherapy Oral Session – Salon B
Moderators:
Objectives: At the end of this session, the participants will be:
 informed about prostate brachytherapy dosimetry, techniques and long term
side-effects including second malignancies, decreasing the dose to the
rectum in cervical HDR brachytherapy and palliative HDR brachytherapy for
endotracheal tumors
1
A PROSPECTIVE COMPARATIVE ANALYSIS OF THREE METHODS OF
RECTAL RETRACTION FOR HIGH DOSE RATE BRACHYTHERAPY IN
CERVICAL CARCINOMA: EFFECT ON ORGANS-AT-RISK
Emilia Timotin, Sachi Voruganti, Rob Hunter, Sean Quinlan-Davidson, Malti
Patel, Gregory Pond, Ranjan Sur, Khavita Dhamanaskar, Iwa Kong
McMaster University, Hamilton, ON
2
ANDROGEN DEPRIVATION THERAPY IN INTERMEDIATE RISK PROSTATE
CANCER PATIENTS TREATED WITH LOW DOSE RATE BRACHYTHERAPY:
A MULTI-INSTITUTIONAL PROPENSITY SCORE MATCHED PAIR ANALYSIS
1
2
2
Jim Rose1, Juanita Crook , Ying (Maggie) Yang , Andrew Warner , James
3
3
4
4
5
Morris , Tom Pickles , Andre-Guy Martin , Eric Vigneault , Charles Catton ,
6
George Rodrigues
1
British Columbia Cancer Agency, Kelowna, BC
2
University of Western Ontario, London, ON
3
British Columbia Cancer Agency, Vancouver, BC
4
L’Hotel Dieu de Quebec, Quebec City, QC
5
Princess Margaret Cancer Centre, Toronto, ON
6
London Health Sciences Centre, London, ON
3
THE INCIDENCE OF SECOND MALIGNANCIES FOLLOWING LOW DOSE
RATE BRACHYTHERAPY FOR PROSTATE CANCER
1
1
1
1
1
Sarah Hamilton , Scott Tyldesley , Jeremy Hamm , Mira Keyes , Tom Pickles ,
1
1
1
2
Vincent Lapointe , Adam Kahnamelli , Michael McKenzie , Stacy Miller , W.
1
James Morris
1
British Columbia Cancer Agency, Vancouver, BC
2
British Columbia Cancer Agency Centre for the North, Prince George, BC
4
RECTAL ULCERS AND RECTO-PROSTATIC FISTULAS FOLLOWING I-125
LDR PROSTATE BRACHYTHERAPY
1
2
2
Nelson Leong , Howard Pai , W. James Morris
1
British Columbia Cancer Agency, Vancouver, BC
2
University of British Columbia, Victoria, BC
5
SALVAGE HDR PROSTATE BRACHYTHERAPY FOR LOCAL FAILURE AFTER
EXTERNAL BEAM RADIOTHERAPY
1
1
1
1
2
Peter Chung , Trish Pulvirenti , Jessy Abed , Anna Simeonov , Gerard Morton ,
1
1
1
3
1
Gerald O’Leary , Alexandra Rink , Jenny Lee , Kristy Brock , Cynthia Ménard
1
Princess Margaret Cancer Centre, Toronto, ON
2
Odette Cancer Centre, Toronto, ON
3
University of Michigan, Ann Arbor, MI
2
6
COMPARISON OF PERMANENT SEED IMPLANT MONOTHERAPY WITH
COMBINED EBRT PLUS HDR BOOST IN INTERMEDIATE RISK PROSTATE
CANCER
Eric Vigneault, André-Guy Martin, Wiliam Foster, Sylviane Aubin, Philippe
Després, Luc Beaulieu
CHU de Québec, Québec, QC
7
A PROSPECTIVE COHORT ANALYSIS OF TWO BRACHYTHERAPY
TECHNIQUES FOR LOW/INTERMEDIATE RISK PROSTATE CANCER
1
2
2
Laura D'Alimonte , Gerard Morton , Andrew Loblaw
1
Odette Cancer Centre, Toronto, ON
2
University of Toronto, Toronto, ON
8
TRACHEAL TUMOURS TREATED PALLIATIVELY WITH ENDOTRACHEAL
BRACHYTHERAPY ALONE: EXPERIENCE FROM A SINGLE INSTITUTION
Nhu-Tram Nguyen, Emilia Timotin, Rob Hunter, Crystal L. Hann, Serge Puksa,
Ranjan Sur
McMaster University, Hamilton, ON
9
REGIONAL DOSE METRICS MAY EXPLAIN CONFLICTING REPORTS
REGARDING THE DOSE-REPONSE FOR LOW DOSE RATE PROSTATE
BRACHYTHERAPY: AN ANALYSIS OF 2000 CONSECUTIVE CASES
1
1
2
1
Jim Morris , Ingrid Spadinger , Chu Jackson , Golshan Maryam
1
British Columbia Cancer Agency, Vancouver, BC
2
University of British Columbia, Vancouver, BC
4:30-6:30
Resident Social
6:30-8:30
CROF Trivia Night
4:30
Optional Tours – on your own
5:00-8:00
CARO Board Meeting – Salon E
3
Tuesday August 26, 2014
7:00-8:00
Meet and Greet – Salon E/F/G
8:00-9:00
Registration and Breakfast - Lobby
9:00-9:15
Welcome and Introductions – Salon B/C/D
9:15-10:45
Theme Symposium
Moderators:
Objectives: At the end of this session, the participants will be able to:
 learn how Canadian euthanasia laws are changing and how this may impact
their oncology practice;
 learn how to manage the stress of working in radiation oncology and
balancing work and personal life to ensure optimal career success, health
and wellbeing .
Euthanasia - Impact of Changing Laws on Canadian Physicians
Manuel Borod
Physician Health and Well-being -- Dealing with Oncology Patients
Optimizing Outcomes
Derek Puddester
10:45-11:45
Break and Poster Viewing – Salon A
11:45-12:45
CARO Lecture – Salon B/C/D
The Changing Face of Head and Neck Cancer 2014
Paul Harari
12:45-2:45
2:30-3:30
Objectives:
At the end of this session, the participants will be able to:
12:45-1:30
1:30-2:15
Lunch in Exhibit Area
Committee Meetings
1:00-2:30
Industry Symposium – Salon E (60) E/F/G (120)
Poster Discussion Session 1 – Salon B
Moderators :
Objectives: At the end of this session, the participants will be able to:
 understand very interesting research presented in poster format and
discussed by the authors which include dosimetry, treatment related toxicity,
target and contours, patient prognosis and outcomes, survival data,
alternative and complementary medicine in cancer patients, and sexual
function following cancer treatment.
10
A DOSIMETRIC STUDY OF REVERSE SEMI-DECUBITUS COMPARED WITH
SUPINE AND BREATH HOLD TECHNIQUES FOR LEFT CHEST WALL AND
INTERNAL MAMMARY CHAIN IRRADIATION
1
1
3
Mark Niglas , Claire McCann , Nadiya Makhani2, Joe Presutti2, Patryk Wohlert ,
2
Justin Lee
1
University of Toronto, Toronto, ON
4
2
Odette Cancer Centre, Toronto, ON
Ryerson University, Toronto, ON
3
11
A RETROSPECTIVE STUDY EVALUATING PATTERNS IN ACUTE SKIN
TOXICITY IN PRONE PATIENTS RECEIVING WHOLE BREAST IRRADIATION
- THE CANADIAN EXPERIENCE
Sandi Bosnic, William Tran, Melanie Davidson, Paulette McKeon, Danny
Vesprini, Jean-Philippe Pignol
University of Toronto, Toronto, ON
12
CLINICAL AND DOSIMETRIC FACTORS RELATED TO RADIATION
PNEUMONITIS: IS COLLAPSED LUNG A SIGNIFICANT FACTOR?
Edwin Chan, Kevin Smith, Agnes Cheung, Charles Cho, Zishan Allibhai, Mojgan
Taremi
Southlake Regional Health Centre, Newmarket, ON
13
DOSIMETRIC IMPACT OF COMBINED ROTATIONAL AND TRANSLATIONAL
SETUP ERRORS ON SPINAL CORD DOSE IN PATIENTS TREATED WITH
SPINE STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR SPINAL
METASTASIS
Alireza Fotouhi Ghiam, Harald Keller, Michael Sharpe, Barbara-Ann Millar, Peter
Chung, David Jaffray, Arjun Sahgal, Daniel Létourneau
University of Toronto, Toronto, ON
14
TARGET VOLUME DEFINITION OF POST-PROSTECTOMY RADIOTHERAPY
(PROSTATE BED) FOR CANCER OF PROSTATE: WHERE IS THE INFERIOR
BORDER?
Mo Manji, Juanita Crook
University of British Columbia, Kelowna, BC
15
THE DEVELOPMENT OF ACUTE ADVERSE BOWEL REACTIONS IN MEN
WITH PROSTATE CANCER TREATED WITH EXTERNAL BEAM RADIATION
THERAPY (EBRT), AND AN ASSOCIATION WITH LIG4 ASP568ASP
Julie Bowen, Michael Conlon, Randall Bissett, Mary Bewick, Adam Andronowski,
Andrew Pearce, Hugh Prichard, David Want
Northeast Cancer Centre Health Sciences North, Sudbury, ON
16
COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) USE FOLLOWING
CANCER DIAGNOSIS
1
1
1
2
2
Pravin Philip Chacko , Ken Le , Ehab Fadhel , Geoffrey Liu , Charles Cho ,
1
1
1
1
1
Louis Fenkell , Mojgan Taremi , Zeeshan Allibhai , Jason Wong , Woody Wells ,
1
Zahra Kassam
1
Stronach Regional Cancer Centre, Newmarket, ON
2
Princess Margaret Cancer Centre, Toronto, ON
17
VAGINAL DOSE AND PATIENT REPORTED SEXUAL ADJUSTMENT WITH
MR-GUIDED BRACHYTHERAPY FOR CERVICAL CANCER
Jennifer Croke, Anthony Fyles, Marco Carlone, Kathy Han, Wilfred Levin, Lee
Manchul, Deborah Williamson, Jason Xie, Michael Milosevic
Princess Margaret Cancer Centre, Toronto, ON
5
6
18
PATIENT OUTCOMES FOR HIGH DOSE RATE BRACHYTHERAPY IN THE
TREATMENT OF CERVICAL CANCER: A RETROSPECTIVE REVIEW
1
2
2
2
3
Angela Lin , Sachi Voruganti , Malti Patel , Robert Hunter , Jeeun An , Gregory
2
2
Pond , Iwa Kong
1
Juravinski Cancer Centre, Hamilton, ON
2
McMaster University, Hamilton, ON
3
Hamilton Health Sciences, Hamilton, ON
19
THE PROGNOSTIC VALUE OF PRE-TREATMENT CIRCULATING
NEUTROPHILS IN OROPHARYNGEAL CANCER BY HPV STATUS
Shao Hui Huang, John Waldron, Xiaowei Shen, Michael Milosevic, Jolie
Ringash, Li Tong, Andrew Bayley, John Kim, Andrew Hope, John Cho, Meredith
Giuliani, Fei-Fei Liu, Wei Xu, Brian O’Sullivan
Princess Margaret Cancer Centre, University of Toronto, Toronto, ON
20
POSTOPERATIVE IMRT FOR PATIENTS WITH ORAL CAVITY CARCINOMA
Sean R. Quinlan-Davidson, William H. Morrison, Jeffrey N. Meyers, Gary B.
Gunn, Faye M. Johnson, Beth M. Beadle, Ann M. Gillenwater, Jack Phan, Steven
J. Frank, William N. William Jr., Clifton D. Fuller,
Kathryn A. Gold, David I. Rosenthal, Adam S. Garden
MD Anderson Cancer Center, Houston, TX
21
PREDICTING SURVIVAL FOLLOWING STEREOTACTIC ABLATIVE
RADIOTHERAPY IN EARLY-STAGE LUNG CANCER: A RECURSIVE
PARTITIONING ANALYSIS TO DEFINE SUBGROUPS
1
2
1
2
Alexander Louie , George Rodrigues , Cornelis Haasbeek , Andrew Warner ,
1
2
1
1
Frank Lagerwaard , David Palma , Ben Slotman , Suresh Senan
1
VU University Medical Center, Amsterdam, Netherlands
2
London Regional Cancer Program, London, ON
Poster Discussion Session 2 – Salon C/D
Moderators : Anthony Brade
Objectives: At the end of this session, the participants will be able to:
 understand research presented in poster format and discussed by the
authors including to identify long-term survivors in limited lung cancer,
understand VMAT in the treatment of advanced lung cancer, review the
safety of stereotactic body radiation therapy in lung cancer, look at testicular
lymphoma outcomes, understand skin cancer contours using fluorescence
markers, hear about patient outcomes in SABR, hear about innovative
software management, learn the results of a Phase 2 clinical trial of
induction chemotherapy followed by SABR, and hear about brain metastases
and spinal metastases treated with stereotactic radiation therapy.
22
CAN WE IDENTIFY LONG-TERM SURVIVORS IN OLIGOMETASTATIC NONSMALL CELL LUNG CANCER (NSCLC)? AN INDIVIDUAL PATIENT DATA
META-ANALYSIS OF OUTCOMES AND PROGNOSTIC FACTORS
Allison Ashworth1, Suresh Senan2, David Palma3, Marc Riquet4, Yong Chan
Ang5, Umberto Ricardi6, Maria Teresa Congedo7, Daniel Gomez8, Gavin
Wright9, Guilio Melloni10, Michael Milano11, Claudio Sole12, Tommaso De
Pas13, Dennis Carter14, Andrew Warner15, George Rodrigues15,
1Queen's University, Kingston, ON
2VU University Medical Center, Amsterdam, Netherlands
7
3University of Western Ontario, London, ON
4Georges Pompidou European Hospital, Paris, France
5Samsung Medical Center, Seoul, Korea
6University of Turin, Turin, Italy
7Catholic University of Sacred Heart, Rome, Italy
8M.D. Anderson Cancer Center, Houston, TX
9University of Melbourne, Melbourne, Australia
10San Raffaele Scientific Institute, Milan, Italy
11University of Rochester, Rochester, NY
12Instituto Madrileño de Oncología, Madrid, Spain
13European Institute of Oncology, Milan, Italy
14Rocky Mountain Cancer Centers, Aurora, CO
23
VMAT MAKES IT POSSIBLE TO TREAT MORE ADVANCED STAGES OF
NON-SMALL CELL LUNG CARCINOMA (NSCLC)
Britta Weber, Mitchell Liu, Eric Berthelet, Karen Goddard, Anky Lai, Alanah
Bergman, Ming Fong, Hannah Carolan
University of British Columbia, Vancouver, BC
24
STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) AND PULMONARY REIRRADIATION: A SYSTEMATIC REVIEW OF THE LITERATURE ASSESSING
SAFETY AND ONCOLOGIC OUTCOMES
Kitty Huang, George Rodrigues, Brian Yaremko, Edward Yu, Rashid Dar, David
Palma
London Regional Cancer Program, London, ON
25
OUTCOMES OF STAGE I-II TESTICULAR LYMPHOMA WITH MODERN
THERAPY
Kim Ann Ung, Richard Tsang, Melania Pintilie, David Hodgson, Alexander Sun,
Vishal Kukreti, John Kuruvilla, Michael Crump, Mary Gospodarowicz
Princess Margaret Cancer Centre, Toronto, ON
26
USE OF PROTOPORPHYRIN FLUORESCENCE TO DETERMINE CLINICAL
TARGET VOLUMES FOR NON-MELANOTIC SKIN CANCERS TREATED WITH
PRIMARY RADIOTHERAPY
Stephanie Casey1, Lara Best2, Olga Vujovic1, Kevin Jordan1, Barbara Fisher3,
Deborah Carey1, Deborah Bourdeau1, James Gilchrist1, Edward Yu3
1London Regional Cancer Program, London, ON
2Calvary Mater Newcastle, Waratah, Australia
3University of Western Ontario, London, ON
27
PATIENT REPORTED OUTCOMES ON THE IMPACT OF SINGLE VERSUS
MULTIPLE FRACTION PALLIATIVE RADIOTHERAPY FOR UNCOMPLICATED
BONE METASTASES ON PAIN, FUNCTION, AND DEGREE OF SYMPTOM
DISTRESS
Jessica Conway1, Ivo Olivotto1, Stacy Miller2, Ross Halperin3, David Hoegler3,
Wayne Beckham4, Joanne Stephen5, Helena Daudt4, John French1, Rob
Olson2
1British Columbia Cancer Agency, Vancouver, BC
2British Columbia Cancer Agency, Centre for the North, Prince George, BC
3British Columbia Cancer Agency, Centre for the Southern Interior, Kelowna, BC
4British Columbia Cancer Agency, Vancouver Island Cancer Centre, Victoria, BC
5British Columbia Cancer Agency, Fraser Valley Cancer Centre, Surrey, BC
8
28
FEASIBILITY OF POPULATION BASED COLLECTION OF PATIENT
REPORTED OUTCOME MEASURES IN A PROVINCIAL RADIOTHERAPY
PROGRAM
Robert Olson1, Helena Daudt2, Joanne Stephen3, John French4, Ross
Halperin5, Gaurav Bahl6, Wayne Beckham2, Ivo Olivotto4
1British Columbia Cancer Agency, Centre for the North, Prince George, BC
2British Columbia Cancer Agency, Vancouver Island Cancer Centre, Victoria, BC
3British Columbia Cancer Agency, Fraser Valley Cancer Centre, Surrey, BC
4British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, BC
5British Columbia Cancer Agency, Centre for the Southern Interior, Kelowna, BC
6British Columbia Cancer Agency, Abbotsford Centre, Abbotsford, BC
29
IMPACTS OF SOFTWARE-BASED MANAGEMENT OF RADIATION
TREATMENT INTERRUPTIONS
Audrey Tetreault-Laflamme1, Luc Ouellet2, Isabelle Gauthier2, Annie Ebacher2,
Myriam Bouchard2
1CHUM, Montreal, QC
2CHUS, Sherbrooke, QC
30
INTERIM ANALYSIS OF A PHASE II CLINICAL TRIAL OF INDUCTION
CHEMOTHERAPY FOLLOWED BY SABR IN BORDERLINE/LOCALLY
ADVANCED PANCREATIC ADENOCARCINOMA
Kimmen Quan, Malolan Rajagopalan, Rodney Wegner, David Clump, John
Flickinger, Steven Burton, Herbert Zeh, Nathan Bahary, Barry Lembersky,
Ronald Stoller, Dwight Heron
University of Pittsburgh, Pittsburgh, PA
31
ISOLATED BRAIN METASTASES AT LUNG CANCER PRESENTATION
TREATED WITH STEREOTACTIC RADIOSURGERY
Fred Hsu1, Roy Ma2, Iulian Badragan1, Michael McKenzie2, Ermias Gete2, Alan
Nichol2
1British Columbia Cancer Agency, Abbotsford, BC
2British Columbia Cancer Agency, Vancouver, BC
32
QUANTITATIVE MRI CHANGES POST-STEREOTACTIC ABLATIVE
RADIOTHERAPY OF THE SPINE
Houda Bahig, Dany Simard, Laurent Létourneau-Guillon, David Roberge, David
Donath, Philip Wong, Édith Filion, Dominic Béliveau-Nadeau, Robert Doucet,
Patsy Nicholson, Laura Masucci
Centre Hospitalier de l'Université de Montréal, Montreal, QC
9
33
INFLUENCE OF PATIENT CHARACTERISTICS AND IMMOBILIZATION ON
INTRAFRACTION MOTION IN EARLY STAGE NON-SMALL CELL LUNG
CANCER TREATED WITH STEREOTACTIC BODY RADIATION THERAPY
David Peterson1, Shaun Loewen2, Ryan Rivest2, Naseer Ahmed2, Ahmet
Leylek2, Bashir Bashir2, Amit Chowdhury2, Ethan Lyn2, Sankar Venkataraman2
1Cancer Care Manitoba, Winnipeg, MB
2University of Manitoba, Winnipeg, MB
3:30-5:00
CARO AGM – Salon B
3:30-6:00
Optional Tour for Families
7:00
Welcome Evening Dinner (includes families)
10
Wednesday August 27, 2014
7:00-8:00
CROF FUN Run/Walk
8:00-9:00
Registration and Breakfast - Lobby
9:00-10:00
Gordon Richards Lecture – Salon B/C/D
Through the Looking Glass: Depictions of Radiation Oncology in the Arts and
Popular Culture
Charles Hayter
Objectives: At the end of this session, the participants will be able to:
 describe depictions of radiation oncology in the arts and popular media; 2. to
discuss the potential impact of these depictions on public and patient
perceptions of radiation oncology.
10:00-11:00
Jean Roy Lecture – Salon B/C/D
APBI - Brachytherapy - Past, Present and will there be a Future?
Douglas Arthur
Objectives:
At the end of this session, the participants will be able to:
11:00-11:30
Break
11:30-1:00
Oral Session 1 – Population Science and Health Services - Salon B
Moderators :
Objectives: At the end of this session, the participants will be able to:

appreciate and understand cancer treatments from a patient perspective –
Guidelines, safety, personal care, impact of patient centered programs,
satellite oncology programs and telehealth, and reducing the burden of
cancer.
34
THE FRACTIONATION OF PALLIATIVE RADIOTHERAPY FOR BONE
METASTASES IN ONTARIO: DO GUIDELINES GUIDE PRACTICE?
Allison Ashworth1, Weidong Kong1, Edward Chow2, William Mackillop1
1Queen's University, Kingston, ON
2Sunnybrook Health Sciences Centre, Toronto, ON
35
MEASURING THE QUALITY OF PERSONAL CARE IN PROSTATE CANCER
RADIOTHERAPY: WHAT ASPECTS OF CARE ARE IMPORTANT TO
PATIENTS?
Kimberley Foley1, Deb Feldman-Stewart1, Michael Brundage1, Siobhan
McArdle2, Patti Groome1, William J. Mackillop1
1Queen's Cancer Research Institute, Kingston, ON
2Cancer Centre of Southeastern Ontario, Kingston, ON
11
36
SPEAK UP FOR PATIENT SAFETY! INTEGRATION OF A RADIOTHERAPY
SPECIFIC PATIENT SAFETY REPORTING CATEGORY INTO A DISTRICT
PATIENT SAFETY REPORTING SYSTEM
Kathryn Moran, Lisa Bourne, Carol-Anne Davis, Helmut Hollenhorst, Kitty Grant,
Beth Kiley
Dalhousie University, Halifax, NS
37
ESTIMATING THE NEED FOR PALLIATIVE RADIOTHERAPY FOR BRAIN
METASTASES: A BENCHMARKING APPROACH
Weidong Kong, Cathryn Jarvis, William Mackillop
Queen’s University Cancer Research Institute, Kingston, ON
38
QUALITY OF LIFE MODULE FOR METASTATIC SPINAL CORD
COMPRESSION DIAGNOSIS: HEALTH CARE PROVIDER AND PATIENT
REPORTED OUTCOMES
Gunita Mitera1, Andrew Loblaw1, Arjun Sahgal1, Markian Pahuta1, Brita
Danielson2, Alysa Fairchild2, Estanislao Arana3, Rocio Romero3, Yvette van der
Linden4, Ernesto Maranzano5, Claudio Piernera5, Dirk Rades6, Anand
Swaminath7
1University of Toronto, Toronto, ON
2University of Alberta, Edmonton, AB
3Fundación Instituto Valenciano de Oncología, Valencia, Spain
4Leiden University, Leiden, Netherlands
5Terni Hospital, Terni, Italy
6University Hospital Schleswig-Holstein, Luebeck, Germany
7McMaster University, Hamilton, ON
39
IMPACT OF PROGRAM-WIDE DISSEMINATION OF THE INCONSISTENT
UTILIZATION OF SINGLE FRACTION RADIOTHERAPY FOR BONE
METASTASES ACROSS A PROVINCIAL PROGRAM
Robert Olson1, Ivo Olivotto2, Manpreet Tiwana1, Mark Barnes1, Ross Halperin3,
Stacy Miller1, David Hoegler3, John French2
1British Columbia Cancer Agency, Centre for the North, Prince George, BC
2British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, BC
3British Columbia Cancer Agency, Centre for the Southern Interior, Kelowna, BC
40
PATIENT-CENTERED CANCER SERVICE DESIGN: WHAT DO PATIENTS
PREFER REGARDING TIME OF DAY, DAY OF WEEK AND TRAVEL
DURATION TO RECEIVE RADIATON THERAPY (RT)?
Ivo Olivotto1, Jenny Soo2, Robert Olson3, Lori Rowe4, Bobbi-Sue Clendenning3,
Andrea Pastuch4, Brigit Jensen5, John French6, Ross Halperin7
1University of Calgary, Calgary, AB
2Vancouver, BC
3University of Northern British Columbia, Prince George, BC
4Surrey, BC
6British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, BC
7British Columbia Cancer Agency, Centre for the Southern Interior, Kelowna, BC
41
TELEHEALTH: A KEY APPROACH TO SUPPORTING AND SUSTAINING
SATELLITE ONCOLOGY SERVICES
Helmut Hollenhorst, Mary Davis, Maureen Nolan, David Bowes, Liam Mulroy,
Robert Rutledge, Pam Robichaud, Holly Lumsden
12
Dalhousie University, Halifax, NS
42
REDUCING THE BURDEN OF CANCER IN LOW-AND-MIDDLE INCOME
COUNTRIES (LMIC): AN INNOVATIVE INTERNATIONAL COLLABORATIVE
MODEL
C. Norman Coleman1, Fei-Fei Liu2, Matthew Parliament3, Raul Urtasun3,
Bhadrasain Vikram3, Mary Gospodarowicz2, Richard C. Love4
1International Cancer Expert Corps, Chevy Chase, MD
2Princess Margaret Cancer Centre, Toronto, ON
3Cross Cancer Institute, University of Alberta, Edmonton, AB
4International Breast Cancer Research Foundation, Madison, WI
11 :30-1 :00
Oral Session 2 – Genitourinary Cancer - Salon C/D
Moderators: Sergio Faria
Objectives:

At the end of this session, the participants will be able to:
learn about interesting and up to date research in prostate and bladder
cancer treatments, such as stereotactic therapy/boost, long term outcomes of
dose escalated IMRT and brachytherapy, risk assessment and biochemical
recurrence, and proteomic signatures.
43
STEREOTACTIC ABLATIVE RADIOTHERAPY IN THE TREATMENT OF
PROSTATE CANCER: DOSIMETRIC AND PATIENT CORRELATES OF
QUALITY OF LIFE
Joelle Helou, Evelyn Elias, Liying Zhang, Patrick Cheung, Andrea Deabreu,
Laura D'Alimonte, Perakaa Sethukavalan, Alexandre Mamedov, Marlene
Cardoso, D. Andrew Loblaw
Odette Cancer Centre, Toronto, ON
44
PATTERNS OF REFERRAL TO RADIATION ONCOLOGY AMONG PATIENTS
WHO UNDERGO CYSTECTOMY FOR INVASIVE BLADDER CANCER IN
ONTARIO: A POPULATION-BASED STUDY
Khaled Zaza, Christopher Booth, D. Robert Siemens, P. Yingwei Peng, David
Berman, Xuejiao Wei, Weidong Kong, William J Mackillop
Queen's University, Kingston, ON
45
COMPARISON OF LDR BRACHYTHERAPY VERSUS EXTERNAL BEAM
RADIATION THERAPY FOR LOW AND INTERMEDIATE-RISK PROSTATE
CANCER: A PROPENSITY-SCORE MATCHED ANALYSIS
George Rodrigues1, Graham Smith2, Juanita Crook3, Andre-Guy Martin4, Eric
Vigneault4, Luis Souhami5, Jim Morris6, Charles Catton7, Himu Lukka8, Andrew
Warner2, Ying Yang2, Tom Pickles3
1London Regional Cancer Program, London, ON
2University of Western Ontario, London, ON
3University of British Columbia, Kelowna, BC
4L'Hotel Dieu de Quebec, Quebec City, QC
5McGill University Health Centre, Montreal, QC
6University of British Columbia, Vancouver, BC
7University of Toronto, Toronto, ON
8McMaster University, Hamilton, ON
13
46
LONG-TERM OUTCOME OF DOSE ESCALATED HYPOFRACTIONATED
INTENSITY MODULATED RADIATION THERAPY (IMRT) FOR LOCALIZED
PROSTATE CANCER
Roger Huang1, Danny Vesprini2, Andrew Bayley1, Robert Bristow1, Peter
Chung1, Mary Gospodarowicz1, Cynthia Ménard1, Michael Milosevic1, Padraig
Warde1, Charles Catton1
1University of Toronto, Toronto, ON
2Sunnybrook Health Sciences Centre, Toronto, ON
47
COMPARISON OF THE CANCER OF THE PROSTATE RISK ASSESSMENT
(CAPRA) WITH THE D’AMICO CLASSIFICATION TO PREDICT FOR
BIOCHEMICAL AFTER EXTERNAL BEAM RADIOTHERAPY (EBRT) OR SEED
PROSTATE BRACHYTHERAPY (PB)
Daniel Taussky1, Vimal Krishnan1, Jean-Paul Bahary1, Sandra Larrivée2, Guila
Delouya1
1Université de Montréal, Montréal, QC
2CRCHUM-Centre de recherche du Centre Hospitalier de l’Université de
Montréal, Montréal, QC
48
LATE URINARY SIDE EFFECTS IN 2011 PATIENTS TREATED WITH LDR
PROSTATE BRACHYTHERAPY: THE BRITISH COLUMBIA CANCER AGENCY
EXPERIENCE
Mira Keyes1, Stacy Miller2, Elisa Chan1, Ross Halperin3, Winkle Kwan4, Vincent
Lapointe1, Michael McKenzie1, W. James Morris1, Ingrid Spadinger1, Tom
Pickles1, Howard Pai5
1British Columbia Cancer Agency, Vancouver, BC
2British Columbia Cancer Agency, Centre for the North, Prince George, BC
3British Columbia Cancer Agency, Centre for the Southern Interior, Kelowna, BC
4British Columbia Cancer Agency, Fraser Valley, Surrey, BC
5British Columbia Cancer Agency, Vancouver Island, Victoria, BC
49
VALIDATION OF A PROTEOMIC SIGNATURE PREDICTING RISK OF
RECURRENCE IN INTERMEDIATE-RISK PROSTATE CANCER
Shawn Malone1, Huijun Zhao2, Suzanne Ackloo3, Jian Chen3, Moyez
Dharsee3, Kenneth Evans3, Peter Kupchak3, Jieran Li3, Girish Sardana3,
Peihong Zhu3, Scott Grimes1, Kyle Malone1, Libni Eapen1, Choan E1, Robert
MacRae1, Gad Perry1, Wayne Kendal1, Julia Craig1, Colin Malone1, Christina
Addison2
1The Ottawa Hospital Cancer Centre, Ottawa, ON
2The Ottawa Hospital Research Institute, Ottawa, ON
3Ontario Cancer Biomarker Network, Toronto, ON
50
STEREOTACTIC BODY RADIOTHERAPY (SBRT) BOOST TO MIMIC HIGHDOSE RATE (HDR) BRACHYTHERAPY FOR INTERMEDIATE-RISK
PROSTATE CANCER: A PHASE I STUDY
Andrew Chiang1, D. Andrew Loblaw1, William Chu1, Suneil Jain2, Darby Erler1,
Ananth Ravi1, Melanie Davidson1, Renee Korol1, Hans Chung1, Danny
Vesprini1, Gerard Morton1, Patrick Cheung1,
1University of Toronto, Toronto, ON
2Queen's University, Kingston, ON
14
51
PELVIC LYMPH NODES DISPLACEMENT IN HIGH-RISK PROSTATE
CANCER PATIENTS TREATED WITH IMAGE-GUIDED IMRT WITH TWO
INDEPENDENT TARGET VOLUMES
Magali Lecavalier-Barsoum1, Luis Souhami2, Fabio Cury2, Marie Duclos2,
Sergio Faria2
1McGill University, Montreal, QC
2McGill University Health Centre, Montreal, QC
1:00-2:40
2:40-4:10
1:00-1:45
1:45-2:30
Lunch in Exhibit Area
Committee Meetings
1:05-2:35
Industry Symposium – Salon E (60) E/F/G (120)
Resident Competition – The Best Of - Salon B/C/D
Moderators:
Objectives: At the end of this session, the participants will be able to:
 gain knowledge of specific treatments, prognostic factors in gynecological,
breast and genitourinary cancers, as well as a system of incident reporting,
and use of feeding tubes in head and neck cancers.
52
ADJUVANT TREATMENT OF STAGE IA TYPE II ENDOMETRIAL CANCERS:
IS OBSERVATION A VALID STRATEGY?
Vikram Velker, Eric Leung, Michel Prefontaine, David D'Souza
University of Western Ontario, London, ON
53
THE PROGNOSTIC SIGNIFICANCE OF PRE-TREATMENT HEMATOLOGIC
FACTORS ON OUTCOME IN PATIENTS WITH CERVICAL CANCER TREATED
WITH RADICAL CHEMORADIOTHERAPY
Theodora Koulis1, Elizabeth Kornaga2, Robyn Banerjee1, Tien Phan1, Prafull
Ghatage1, Anthony M. Magliocco3, Susan P. Lees-Miller1, Corinne M. Doll1
1University of Calgary, Calgary, AB
2Tom Baker Cancer Centre, Calgary, AB
3H. Lee Moffitt Cancer Center, Tampa, FL
54
A NATIONAL SYSTEM FOR INCIDENT REPORTING IN RADIATION THERAPY
(NSIR-RT): TAXONOMY DEVELOPMENT UTILIZING A DELPHI PROCESS
C. Suzanne Drodge1, Brian Liszewski2, Eve-Lyne Marchand3, Gunita Mitera2,
Jean-Pierre Bissonnette4,
Peter Dunscombe5, Matthew Parliament1, Spencer Ross6, Michael Brundage7,
Kathryn Moran8, Michael Milosevic4
1University of Alberta, Edmonton, AB
2CPQR, Toronto, ON
3CPQR, Montreal, QC
4University of Toronto, Toronto, ON
5University of Calgary, Calgary, AB
6CPQR, Ottawa, ON
7Queen's University, Kingston, ON
8CPQR, Halifax, NS
55
ACCELERATED HYPOFRACTIONATED POST-OPERATIVE RADIOTHERAPY
OF PROSTATE CANCER: A PROSPECTIVE PHASE I/II STUDY
15
Adam Gladwish, Andrew Loblaw, Patrick Cheung, Gerard Morton, Hans Chung,
Andrea Deabreu, Geordi Pang, Alexandre Mamedov
University of Toronto, Toronto, ON
56
COMPARISION OF ACTIVE SURVEILLANCE, LOW DOSE RATE
BRACHYTHERAPY,STANDARD EXTERNAL BEAM RADIOTHERAPY AND
STEREOTACTIC ABLATIVE BODY RADIOTHERAPY IN LOW RISK
PROSTATE CANCER
Hima Bindu Musunuru1, Perakaa Sehukavalan1, Patrick Cheung2, Gerard
Morton1, Laura D’Alimonte1, Andrea Deabreu2, Alexandre Mamedov2, Liying
Zhang2, Hans Chung1, Andrew Loblaw1
1University of Toronto, Toronto, ON
2Odette Cancer Centre, Toronto, ON
57
EVALUATION OF CARDIAC DOSE REDUCTION WITH DEEP INSPIRATION
BREATH HOLD IN PATIENTS WITH LEFT-SIDED BREAST CANCER
RECEIVING ADJUVANT RADIOTHERAPY
Rosanna Yeung, Karen Long, Daphne Walrath, Wendy Smith, Alana Hudson,
Tien Phan
University of Calgary, Calgary, AB
58
SECOND MALIGNANCIES AFTER ADJUVANT RADIOTHERAPY FOR EARLY
STAGE BREAST CANCER: IS THERE AN INCREASED RISK WITH THE
ADDITION OF REGIONAL RADIOTHERAPY?
Sarah Hamilton1, Scott Tyldesley1, Dongdong Li1, Robert Olson2, Mary
McBride1
1British Columbia Cancer Agency, Vancouver, BC
2British Columbia Cancer Agency, Prince George, BC
59
PROVINCIAL CHANGES IN ADJUVANT RADIOTHERAPY USE AND
HORMONE THERAPY COMPLIANCE AFTER THE PUBLICATION OF CALGB
9343, IN ELDERLY, EARLY STAGE, ESTROGEN RECEPTOR POSITIVE
BREAST CANCER PATIENTS TREATED WITH LUMPECTOMY
Sarah Lucas1, Elisa Chan2, Scott Tyldesley1, Sally Smith3, Caroline Speers1,
Alan Nichol1
1British Columbia Cancer Agency, Vancouver, BC
2Saint John Regional Hospital, Saint John, NB
3British Columbia Cancer Agency, Victoria, BC
60
TIMING OF FEEDING TUBE INSERTION AND COMPLICATIONS AFTER
HEAD AND NECK CANCER RADIOTHERAPY: A POPULATION BASED
COMPARATIVE MARKET
Jocelyn Moore, Harvey Quon, Angela Martens, Candace Myers, Pascal Lambert
University of Manitoba, Winnipeg, MB
4:10-4:30
Break
4:30-6:00
Oral Session 3 – Survivorship and Education - Salon B
Moderators: Meredith Giuliani, Joanne Alfieri
16
Objectives: At the end of this session, the participants will be able to:
 understand the survivorship needs of cancer patients, sexual health issues,
quality of life of our patients, and the quality of online educations and
integrating oncology into medical education, and a review of our CARO
abstract publications.
61
THE PREVALENCE AND NATURE OF SURVIVORSHIP NEEDS IN HEAD AND
NECK CANCER PATIENTS
Meredith Giuliani, Maurene McQuestion, Jennifer Jones, Alison Ross, Nour
Alkazaz, Terry Cheng, John Waldron, Pamela Catton, Jolie Ringash
Princess Margaret Cancer Centre, Toronto, ON
62
IDENTIFICATION OF UNMET SURVIVORSHIP NEEDS IN PRIMARY LUNG
CANCER PATIENTS: A HIGH BURDEN FOR YOUNGER PATIENTS
Robin Milne1, Jennifer Kwan1, Shabbir Alibhai2, Doris Howell1, Jennifer
Marshall1, Thomas Waddell1, Nazek Abdelmutti1, Geoffrey Liu1, Jennifer
Jones1, Pamela Catton1, Martine Puts2, Meredith Giuliani1
1Princess Margaret Cancer Centre, Toronto, ON
2University of Toronto, Toronto, ON
63
RESULTS OF A PROVINICAL SUVIVORSHIP TRANSITION PILOT
Jonathan Sussman1, Maria Grant2, Amanda Calzolaio2
1Juravinski Cancer Centre, Hamilton, ON
2Cancer Care Ontario, Toronto, ON
64
IMPLEMENTING A SURVIVORSHIP PROGRAMME FOR HEAD AND NECK
CANCER PATIENTS
Jolie Ringash, Maurene McQuestion
Princess Margaret Cancer Centre, Toronto, ON
65
SEXUAL HEALTHCARE IN CANCER PATIENTS: AWARENESS AND ROLE
PERCEPTIONS OF RADIATION THERAPISTS.
Angela Turner, Odette Cancer Centre, Toronto, ON
66
SIFTING THROUGH IT ALL: THE QUALITY OF ONLINE EDUCATIONAL
RESOURCES FOR OVARIAN CANCER PATIENTS
Paris-Ann Ingledew1, Irene Yu2
1British Columbia Cancer Agency, Fraser Valley, Vancouver, BC
2University of British Columbia, Vancouver, BC
67
NOT JUST AN ADD-ON SUBJECT: INTEGRATING ONCOLOGY INTO THE
HEART OF UNDERGRADUATE MEDICAL EDUCATION
17
Jennifer Kwan1, Joyce Nyhof-Young2, Pamela Catton2, Meredith Giuliani2
1Queen's University, Kingston, ON
2University of Toronto, Toronto, ON
68
PUBLICATION RATES OF ABSTRACTS PRESENTED AT THE 2007 AND 2010
CANADIAN ASSOCIATION OF RADIATION ONCOLOGY (CARO) MEETINGS
Aliza Meissner, Guila Delouya, David Marcovitch, David Donath, Daniel Taussky
Université de Montréal, Montreal, QC
69
HEALTH-RELATED QUALITY OF LIFE OUTCOMES FROM CANCER
CLINICAL TRIALS: WHAT ARE THE FACTORS INFLUENCING THEIR USE IN
ONCOLOGY PRACTICE?
Michael D. Brundage1, Julie Rouette1, Melanie Calvert2, Madeleine King3, Jane
Blazeby4, Melanie Walker1, Yingwei Peng1, Jolie Ringash5, Ralph M. Meyer6
1Queen's University, Kingston, ON
2University of Birmingham, Birmingham, United Kingdom
3The University of Sydney, Sydney, Australia
4University of Bristol, Bristol, United Kingdom
5University of Toronto, Toronto, ON
6Juravinski Cancer Centre, Hamilton, ON
4 :30-6 :00
Oral Session 4 – Radiation Treatment Delivery - Salon C/D
Moderators :
Objectives: At the end of this session, the participants will be able to:
 understand several techniques to optimize the planning and delivery of
radiation treatments to continue to reduce the uncertainty of radiation therapy
delivery and improve patient outcomes.
70
INTRAFRACTION CONE BEAM COMPUTED TOMOGRAPHY IMAGING
EVALUATION DURING STEREOTACTIC BODY RADIATION THERAPY FOR
LUNG TUMOURS AND METASTATIC TUMOURS TO THE SPINE
Ziad Simon Fawaz, Dominique Mathieu, Laura Masucci, Louise Lambert, Edith
Filion
University of Montreal, Montreal, QC
71
SURVIVAL AND DOSIMETRY FROM A CLINICAL TRIAL OF ADAPTIVE
RADIOTHERAPY FOR LIMITED-STAGE SMALL CELL LUNG CANCER
Lindsay Rowe1, Andra Krauze2, John Hanson3, Don Yee3
1University of Alberta, Edmonton, AB
2National Institutes of Health/ National Cancer Institute, Bethesda, MD
3Cross Cancer Institute, Edmonton, AB
72
A NEW, INNOVATIVE, NON-INVASIVE APPROACH USED TO ASSIST IN THE
VISUALIZATION, SETUP AND NEEDLE PLACEMENT FOR INITIATING A
BREAST BRACHYTHERAPY PROGRAM WITH PALLADIUM 103 PERMANENT
BREAST SEED IMPLANTS (PBSI)
Karen Long, Tyler Meyer, Derek Brown, Siraj Husain
18
Tom Baker Cancer Center, Calgary, AB
73
VISUALLY MONITORED DEEP INSPIRATION BREATH HOLD TECHNIQUE IN
LEFT-SIDED BREAST CANCER PATIENTS TREATED WITH ADJUVANT
RADIOTHERAPY: REPRODUCIBILITY AND RELIABILITY
Rosanna Yeung, Leigh Conroy, Karen Long, Wendy Smith, Alana Hudson,
Roseanne Moore, Coline Dirkse, Tien Phan
University of Calgary, Calgary, AB
74
TURN DOWN THE NOISE — A BLINDED EVALUATION OF ITERATIVE
RECONSTRUCTION IN RADIOTHERAPY IMAGING
Nhu-Tram Nguyen1, Guy Charron2, David Roberge2
1Juravinski Cancer Centre, Hamilton, ON
2Université de Montréal, Montreal, QC
75
ORGAN DOSE REDUCTION WHILE USING IN-HOUSE CBCT PATIENTSPECIFIC PROTOCOLS BASED ON OSL DOSIMETRY
Étienne Létourneau, Fabiola Vallejo Castaneda, Martin Hinse
Université de Montréal, Laval, QC
76
OPTIMIZATION OF CT-SCAN PROTOCOL AND IMAGES FOR TREATMENT
PLANNING OF HEAD & NECK CASES FOR RADIATION THERAPY
Francois Germain, Rasika Rajapakshe, Leigh Bartha, Victoria van de Leest
British Columbia Cancer Agency, Kelowna, BC
77
DOSIMETRY, IMAGE GUIDANCE AND CLINICAL OUTCOMES OF SUBCENTIMETER LUNG TUMOURS AFTER STEREOTACTIC ABLATIVE
RADIOTHERAPY
Alexander Louie, Suresh Senan, Max Dahele, Ben Slotman, Wilko Verbakel
VU University Medical Center, Amsterdam, Netherlands
78
A PLANNING COMPARISON OF 3D CONFORMAL MULTIPLE STATIC FIELD,
CONFORMAL ARC AND VOLUMETRIC MODULATED ARC THERAPY FOR
THE DELIVERY OF STEREOTACTIC BODY RADIOTHERAPY FOR EARLY
STAGE LUNG CANCER
Mike Dickey1, Wilson Roa2, C. Suzanne Drodge2, Sunita Gosh2, Brad Murray2,
Rufus Scrimger2, Zsolt Gabos2
1University of Alberta, Edmonton, AB
2Cross Cancer Institute, Edmonton, AB
6:15
Cocktail Awards Ceremony – Salon A
Thursday August 28, 2014
7:30-8:00
Registration and Breakfast – Salon A
8:00-9:30
Oral Session 5 – Breast and Gynecologic Cancers - Salon B
Moderators :
Objectives: At the end of this session, the participants will be able to:
 look at breast and gynecology radiation therapy from various aspects
including comparison of toxicity, adjuvant therapy, cost of brachytherapy
19
methods versus external beam, and interesting aspects concerning vaginal,
vulvar and cervical treatments.
79
NEW ASPECTS CONCERNING THE RADIATION OF BREAST CANCER
Edwin Boelke1, Christiane Matuschek1, Kai Kammers2, Carolin Nestle
Kraemling1, Wilfried Budach1
1Heinrich Heine University, Dusseldorf, Germany
2Johns Hopkins University, Baltimore, MD
80
COMPARISON OF THE PREVALENCE OF ARM SYMPTOMS AND ARM
SWELLING IN BREAST CANCER PATIENTS TREATED WITH
HYPOFRACTIONATED COMPARED TO CONVENTIONAL FRACTIONATED
NODAL RADIATION THERAPY IN THE MODERN ERA OF CT-BASED RT
PLANNING
Nelson Leong1, Pauline Truong2, Cheryl Alexander3, Bradley Wiksyk3, Lorna
Weir2, Keith Tankel4, C. Suzanne Drodge5, Winkle Kwan2
1British Columbia Cancer Agency, Vancouver, BC
2University of British Columbia, Victoria, BC, Canada
3British Columbia Cancer Agency, Vancouver Island Centre, Victoria, BC
4University of Alberta, Edmonton, AB
5Cross Cancer Institute, Edmonton, AB
81
POPULATION-BASED ANALYSIS OF THE IMPACT AND GENERALIZABILITY
OF THE NSABP B24 STUDY ON ENDOCRINE THERAPY (ET) FOR DUCTAL
CARCINOMA IN SITU (DCIS) OF THE BREAST
Andrea Lo1, Pauline Truong2, Elaine Wai2, Alan Nichol1, Lorna Weir1, Caroline
Speers1, Malcolm Hayes1, Scott Tyldesley1
1University of British Columbia, Vancouver, BC
2University of British Columbia, Victoria, BC
82
THE COST OF CONVENIENCE: A COST COMPARISON ANALYSIS OF
EXTERNAL BEAM RADIATION THERAPY, HIGH-DOSE RATE
BRACHYTHERAPY AND PERMANENT SEED IMPLANTS FOR EARLY STAGE
BREAST CANCER
Merrylee McGuffin1, Jean-Philippe Pignol2, Brian Keller2
1Sunnybrook Health Sciences Centre, Toronto, ON
2University of Toronto, Toronto, ON
83
NEOADJUVANT SYSTEMIC THERAPY UTILIZATION IN BREAST CANCER:
POTENTIAL IMPACT ON NODAL RADIOTHERAPY
Kwamena Beecham1, Scott Tyldesley2, Caroline Speers2, Christine Simmons2,
Rona Cheifitz2, Michelle Sutter1, David Voduc2, Robert Olson1
1British Columbia Cancer Agency, Prince George, BC
2British Columbia Cancer Agency, Vancouver, BC
84
TRANSVAGINAL ULTRASOUND-GUIDED TRANSPERINEAL INTERSTITIAL
BRACHYTHERAPY FOR VAGINAL TUMOURS: A FIXED TEMPLATE
TECHNIQUE
Jim Rose, Francois Bachand, David Petrik, Deidre Batchelar, Matthew Schmid,
Juanita Crook
Brtitish Columbia Cancer Agency, Kelowna, BC
20
85
ADVANCED CARCINOMA OF THE VULVA: OUTCOMES AND PATTERN OF
RECURRENCES
Francois Bachand1, Melanie Harrott1, Christina Aquino-Parsons2, Peter Lim2,
Mo Manji1, Beverly Lester3, Frances Wong3, Jennifer Goulart4, David Petrik1,
Juanita Crook1, Caroline Holloway4
1British Columbia Cancer Agency, Sindi Ahluwalia Hawkins Centre for the
Southern Interior, Kelowna, BC
2British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, BC
3British Columbia Cancer Agency, Abbotsford Cancer Center, Abbotsford, BC
4British Columbia Cancer Agency, Vancouver Island Cancer Center, Victoria, BC
86
PELVIC AND PARA-AORTIC RADIOTHERAPY: AN EFFECTIVE AND SAFE
TREATMENT IN STAGE IIIC AND IVB CARCINOMA OF THE UTERUS
Boris Bahoric, Alexander Rabinovich, Laurence Bernard, Walter Gotlieb
Jewish General Hospital, McGill University, Montreal, QC
87
LONG-TERM OUTCOMES AND LATE EFFECTS OF DEFINITIVE CHEMORADIOTHERAPY IN PATIENTS WITH CERVICAL CANCER IN NOVA SCOTIA
Benjamin Royal-Preyra1, David Bowes2, Gaurav Bahl3, Paul Joseph2, Maureen
Nolan2, Hylkije Ymeri2, Nikhilesh Patil2
1Dalhousie University, Halifax, NS
2Nova Scotia Cancer Centre, Halifax, NS
3British Columbia Cancer Agency, Abbotsford, BC
8 :00-9 :30
Oral Session 6 – Biology and CNS - Salon C/D
Objectives: At the end of this session, the participants will be able to:
 understand more about the biology of cancer resistance, circulating tumor
cells, hypoxia, toxicity and esophagitis, as well as be introduced to innovative
and promising radiation techniques for treating our patients with brain
tumors.
88
MIR-330-3P AND CANCER RADIATION RESISTANCE
Stanley Liu, Xiaoyong Huang, Samira Taeb, Sahar Jahangiri, Jeff Bruce, Rob
Bristow, Fei-Fei Liu
University of Toronto, Toronto, ON
89
SIGNIFICANCE OF CIRCULATING TUMOR CELLS (CTCS) IN PROSTATE
CANCER PATIENTS UNDERGOING ADJUVANT OR SALVAGE RADIATION
THERAPY
Lori Lowes, Alison Allan, Tracy Sexton
University of Western Ontario, London, ON
90
THE RELATIONSHIP BETWEEN CIRCULATING CD34+ CELLS WITH MENTAL
FATIGUE AND INSOMNIA DURING ADJUVANT BREAST CANCER
RADIATION THERAPY (RT)
Tim Lymberiou1, Kathy Han1, Madeline Li1, Willa Shi2, Xiaowei Shen3, Wei
Xu3, Pamela Catton1, Anthony Fyles1, Robert Sutherland3, Ryan Carlson1, Mei
Ling Yap1, Mark Minden1, Fei-Fei Liu1
1University of Toronto, Toronto, ON
2Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, ON
21
3University Health Network, Toronto, ON
91
TUMOUR HYPOXIA IS ASSOCIATED WITH INFERIOR SURVIVAL AFTER
RADIOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER
Nafisha Lalani1, Shaun Tolan1, Melanie Pintilie2, Srikala Sridhar1, Peter
Chung1, Mary Gospodarowicz1, Alan Evans1, Robert Bristow1, Michael
Milosevic1
1University of Toronto, Toronto, ON
2Princess Margaret Cancer Centre, Toronto, ON
92
PREDICTING ESOPHAGITIS DURING RADICAL LUNG RADIOTHERAPY
USING 18-FDG PET
Qurrat Mehmood, Alex Sun, Nathan Becker, Jane Higgins, Andrea Marshall, Lisa
Le, Paula McCloskey, Victoria Ford, Katy Clarke, Mei Yap, Andrea Bezjak, JeanPierre Bissonnette
Princess Margaret Cancer Centre, Toronto, ON
93
ASSESSMENT OF RENAL TOLERANCE AFTER STEREOTACTIC BODY
RADIOTHERAPY IN A LARGE ANIMAL MODEL – THE EFFECTS OF
TREATMENT VOLUME AND LOCATION OVER TIME
Fabio Cury, Nita Patel, Fadi Brimo, Christine Hudon, Dufour Natalie, Rahul Bera,
Horacio Patrocinio
McGill University Health Centre, Montreal, QC
94
VERTEBRAL COMPRESSION FRACTURE (VCF) AFTER SPINE
STEREOTACTIC BODY RADIOTHERAPY (SBRT): ANALYSIS OF
PREDICTIVE RISK FACTORS FOR DE NOVO VERSUS PROGRESSION OF
AN EXISTING FRACTURE
Chia-Lin Tseng1, Isabelle Thibault1, Eshetu G. Atenafu2, Samuel T. Chao3,
Ameen S. Al-Omair4, Nicholas S. Boehling5, Ehsan H. Balagamwala6, Marcelo
Cunha1, Lilyana Angelov3, Paul D. Brown5, John H. Suh3, Laurence D.
Rhines5, Michael G. Fehlings1, Eric L. Chang7, Arjun Sahgal1
1University of Toronto, Toronto, ON
2University Health Network, Toronto, ON
3Cleveland Clinic, Cleveland, OH
4Princess Margaret Cancer Centre, Toronto, ON
5 The University of Texas M.D. Anderson Cancer Center, Houston, TX
6Cleveland Clinic, Cleveland, OH
7University of Southern California, Los Angeles, CA
95
A PHASE II STUDY OF WHOLE BRAIN RADIOTHERAPY (WBRT) WITH
SIMULTANEOUS INTEGRATED BOOST (SIB) USING VOLUMETRIC
MODULATED ARC THERAPY FOR ONE TO TEN BRAIN METASTASES
Alan Nichol1, Michael McKenzie1, Roy Ma1, Fred Hsu2, Arthur Cheung3,
Lovedeep Gondara1, Michael Peacock1, Hannah Carolan1, Robert Olson4,
Francois Germain5, Devin Schellenberg3, Rosemin Vellani1
1University of British Columbia, Vancouver, BC
2University of British Columbia, Abbotsford, BC
3University of British Columbia, Surrey, BC
4University of British Columbia, Prince George, BC
5University of British Columbia, Kelowna, BC
96
22
ENCOURAGING RESULTS OF A PHASE II TRIAL OF NEOADJUVANT
TEMOZOLOMIDE (NEO-TMZ), CONCURRENT TMZ PLUS
HYPOFRACTIONATED ACCELERATED RADIOTHERAPY (HART), AND
ADJUVANT TMZ IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM)
George Shenouda1, Luis Souhami2, Kevin Petrecca1, Scott Owen1, Valerie
Panet-Raymond1, Marie-Christine Guiot1, Bassam Abdulkarim1
1McGill University, Montréal, QC
2McGill University Health Centre, Montreal, QC
9:30-9:50
Break
9:50-10:50
Reviewer’s Choice – Salon B
Moderators: Fabio Cury/George Rodrigues
Objectives: At the end of this session, the participants will be able to:
 understand a variety of interesting and select topics of radiation therapy
innovations, quality of care, and quality of life measurements and how these
impact our cancer population.
97
ESTIMATING THE POPULATION IMPACT OF INTRODUCING
STEREOTACTIC ABLATIVE RADIOTHERAPY FOR STAGE I NSCLC IN
CANADA
Alexander Louie1, George Rodrigues2, David Palma1, Suresh Senan2
1VU University Medical Center, Amsterdam, Netherlands
2London Regional Cancer Program, London, ON
98
VOLUME OF PRACTICE AND OUTCOMES AFTER RADIOTHERAPY FOR
HEAD AND NECK CANCER
Timothy Owen, Khaled Zaza, Weidong Kong, Chris Booth, William Mackillop
Queen's University, Kingston, ON
99
THE NATIONAL SYSTEM FOR INCIDENT REPORTING IN RADIATION
THERAPY (NSIR-RT): DEVELOPMENT OF A SEVERITY CLASSIFICATION
Brian Liszewski1, Eve-Lyne Marchand1, C. Suzanne Drodge2, Michael
Brundage3, Gunita Mitera1, Kathryn Moran4, Jean Pierre Bissonnette1, Peter
Dunscombe5, Spencer Ross6, Matthew Parliament7, Michael Milosevic8
1Canadian Partnership for Quality in Radiotherapy, Toronto, ON
2Cross Cancer Institute, Edmonton, AB
3Canadian Partnership for Quality in Radiotherapy, Kingston, ON
4Canadian Partnership for Quality in Radiotherapy, Halifax, NS
5University of Calgary, Calgary, AB
6Canadian Institute for Health Information, Ottawa, ON
7Canadian Partnership for Quality in Radiotherapy, Edmonton, AB
8Canadian Institute for Health Information, Toronto, ON
100
NEUTROPHILS MODULATE RESPONSE TO RADIATION AND
CHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER
23
Rachel Glicksman, Naz Chaudary, Melania Pintilie, Karolina Jaluba, Blaise
Clarke, Richard Hill, Kathy Han, Anthony Fyles, Michael Milosevic
Princess Margaret Cancer Centre, Toronto, ON
101
RADIOTHERAPY QUALITY OF CARE INDICATORS FOR LOCALLY
ADVANCED CERVIX CANCER: A CANADIAN CONSENSUS
Jennifer Croke1, Michael Milosevic1, Anthony Fyles1, Lisa Barbera2, Brita
Danielson3, David D’Souza4, Robert Pearcey5, Teri Stuckless6, Brenda Bass7,
Michael Brundage7
1Princess Margaret Cancer Centre, Toronto, ON
2Odette Cancer Centre, Toronto, ON
3Cross Cancer Institute, Edmonton, AB
4London Regional Cancer Centre, London, ON
5Tom Baker Cancer Centre, Calgary, AB
6Dr. H. Bliss Murphy Cancer Centre, St. John, NL
7Queen's University, Kingston, ON
102
QUALITY OF LIFE OF PATIENTS TREATED FOR LOCALIZED PROSTATE
CANCER: STEREOTACTIC RADIOTHERAPY VERSUS EXTERNAL BEAM +
HIGH DOSE RATE BRACHYTHERAPY BOOST
Joelle Helou, Gerard Morton, Liying Zhang, Andrea Deabreu, Laura D'Alimonte,
Alexandre Mamedov, Ananth Ravi, Hans Chung, Patrick Cheung, Andrew
Loblaw
Odette Cancer Centre, Toronto, ON
11:00-12:30
CARO ESTRO Symposium – Salon B
Objectives: At the end of the session, participants will be able to:
 review potentially practice changing results of recent breast cancer
randomized trials pertaining to:
o Locoregional RT for stage II and high-risk stage I breast cancer
following mastectomy or breast conserving surgery,
o The role and technical limitations of partial breast RT for early-stage
breast cancer following breast conserving surgery.
 foster collaboration between European and Canadian Radiation Oncology
communities.
The Eye of the Beholder- European and Canadian Perspectives on Breast
Radiotherapy
Philip Poortsmans
Ivo Olivotto
12:30-12:45
Close
2:00
Optional Tours – on your own
24
POSTER ABSTRACTS
103
IS PROPHYLACTIC CRANIAL IRRADIATION WITH HIPPOCAMPAL AVOIDANCE JUSTIFIED
IN LIMITED STAGE SMALL CELL LUNG CANCER?
1
2
3
2
Alexander Louie , Mark Mishra , Vinai Gondi , Minesh Mehta
1
VU University Medical Center, Amsterdam, Netherlands
2
University of Maryland, Baltimore, MD
3
University of Wisconsin, Madison, WI
104
COMPARISON OF PATTERNS OF LOCAL RECURRENCE IN EARLY STAGE BREAST
CANCER ACCORDING TO MARGIN STATUS: A LONG-TERM FOLLOW-UP STUDY
1
1
1
2
1
1
Kitty Huang , Olga Vujovic , Edward Yu , Anil Cherian , Rashid Dar , Larry Stitt , Francisco
1
Perera
1
London Regional Cancer Program, London, ON, Canada
2
UK Ministry of Defense, United Kingdom
105
PREDICTORS OF BREAST RADIOTHERAPY PLAN MODIFICATIONS: QUALITY ASSURANCE
ROUNDS IN A LARGE CANCER CENTRE
1
1
1
2
2
1
Tim Lymberiou , Susanne Galuszka , Grace Lee , Wei Xu , Susie Su , Anthony Fyles , Thomas
1
1
1
1
1
1
Purdie , Pamela Catton , Caroline Chung , Robert Dinniwell , Kathy Han , Anne Koch , Wilfred
1
1
1
1
1
Levin , Lee Manchul , Joshua Sappiatzer , Penny Mackenzie , Fei-Fei Liu
1
Princess Margaret Cancer Centre, Toronto, ON
2
University Health Network, Toronto, ON
106
A NOVEL BREAST IMMOBILIZATION DEVICE TO IMPROVE OUTCOMES OF PATIENTS
WITH PENDULOUS BREAST UNDERGOING WHOLE-BREAST RADIOTHERAPY
1
2
2
2
2
Magali Lecavalier-Barsoum , Suzanne Rossel , Nancy Raffis , Naomi Shin , Emilie Soisson ,
2
2
2
2
2
Christine Lambert , Marie Duclos , Marc David , Valerie Panet-Raymond , Neil Kopek , Bassam
2
2
Abdulkarim , Tarek Hijal
1
McGill University, Montreal, QC
2
McGill University Health Centre, Montreal, QC
107
OUTCOMES BASED ON TUMOUR RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY IN
BREAST CANCER
1
2
2
2
2
Ziad Simon Fawaz , Peter Vavassis , David H. Nguyen , Bernard Fortin , Lucas Sideris , Michael
2
Yassa
1
University of Montreal, Montreal, QC
2
Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, QC
108
BREAST CANCER PATIENT PREFERENCES FOR ADJUVANT RADIOTHERAPY POSTLUMPECTOMY: WHOLE BREAST IRRADIATION VERSUS PARTIAL BREAST IRRADIATION –
PRELIMINARY RESULTS
1
1
1
1
2
Ewa Szumacher , Merrylee McGuffin , Lisa DiProspero , Tamara Harth , Deb Feldman-Stewart ,
1
1
1
1
1
Jean-Philippe Pignol , Edward Chow , Danny Vesprini , Eileen Rakovitch , Justin Lee , Mary
1
1
1
Doherty , Alex Kiss , Roseanna Presutti
1
Sunnybrook Health Sciences Centre, Toronto, ON
2
Queen's Cancer Research Institute, Kingston, ON
109
PREDICTIVE MARKERS FOR CLINICAL OUTCOME AFTER NEOADJUVANT
RADIOCHEMOTHERAPY IN BREAST CANCER PATIENTS
Christiane Matuschek, Edwin Boelke, Hans Bojar, Carolin Nestle-Kraemling, Werner Audretsch,
25
Wilfried Budach
Dusseldorf, Germany
110
A CROSS-SECTIONAL COHORT STUDY OF CEREBROVASCULAR ABNORMALITIES AFTER
RADIATION THERAPY FOR CRANIOPHARYNGIOMA
1
1
2
2
2
3
Andrea Lo , A. Fuchsia Howard , Alan Nichol , Haroon Hasan , Monty Martin , Manraj Heran ,
1
Karen Goddard
1
University of British Columbia, Vancouver, BC
2
British Columbia Cancer Agency, Vancouver Centre, Vancouver, BC
3
Vancouver General Hospital, Vancouver, BC
111
DEFINING THRESHOLDS FOR VOLUMETRIC RESPONSE AS COMPARED TO RESPONSE
EVALUATION CRITERIA IN SOLID TUMOURS (RECIST) AFTER RADIOTHERAPY FOR
BRAIN METASTASES
1
1
1
2
3
1
Michael Peacock , Michael McKenzie , Roy Ma , Fred Hsu , Arthur Cheung , Hannah Carolan ,
4
5
3
1
Robert Olson , Francois Germain , Devin Schellenberg , Alan Nichol
1
British Columbia Cancer Agency, Vancouver, BC
2
British Columbia Cancer Agency, Abbotsford, BC
3
British Columbia Cancer Agency, Surrey, BC
4
British Columbia Cancer Agency, Prince George, BC
5
British Columbia Cancer Agency, Kelowna, BC
112
THE VALIDITY OF MEDICAL CERTIFICATES OF DEATH IN PATIENTS WITH
CRANIOPHARYNGIOMA
Andrea Lo, Haroon Hasan, A. Fuchsia Howard, Karen Goddard
University of British Columbia, Vancouver, BC
113
ADUJVANT RADIOTHERAPY IN PARTIALLY RESECTED NON-FUNCTIONING
MACROADENOMAS: WHEN TO RECOMMEND?
Khusraw Sabit, Valerie Panet-Raymond, Luis Souhami, Issam El Naqa, George Shenouda,
Bassam Abdulkarim, Anthony Zeitouni, Denis Sirhan
McGill University Health Centre, Montreal, QC
114
EVALUATION OF PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA (EPPIG)
Michael J Kucharczyk, Sameer Parpia, Anthony Whitton, Jeffrey N Greenspoon
McMaster University, Hamilton, ON
115
KNOWLEDGE TO ACTION IN CANADIAN RADIATION ONCOLOGY PRACTICE CONVERSION OF ACCEPTED CARO ABSTRACTS TO THEIR PEER-REVIEWED
PUBLICATIONS
1
2
1
Aananthan Thangaroopan , Gunita Mitera , Anand Swaminath
1
McMaster University, Hamilton, ON
2
University of Toronto, Toronto, ON
116
EVALUATING THE IMPACT OF A NATIONAL ANATOMY AND RADIOLOGY CONTOURING
(ARC) BOOTCAMP FOR RADIATION ONCOLOGY RESIDENTS
Jasbir Jaswal, Leah D'Souza, Marjorie Johnson, Katherine Willmore, Keng Yeow Tay, Mark
Landis, Zahra Kassam, Eric Leung, David D'Souza, Tracy Sexton, Anthony Nichols, David
Anthony Palma
University of Western Ontario, London, ON
117
26
A NATIONAL SURVEY ON PEER REVIEW: CANADIAN RADIATION ONCOLOGISTS’ VIEWS
REGARDING THE BENEFITS, PRACTICAL WORKLOAD IMPLICATIONS AND LEGAL
LIABILITY
1
1
1
1
2
Sarah Hamilton , Haroon Hasan , Christina Parsons , Scott Tyldesley , Fuschia Howard , Mary
2
1
Anne Bobinski , Karen Goddard
1
British Columbia Cancer Agency, Vancouver, BC
2
University of British Columbia, Vancouver, BC
118
PROVIDING PATIENT CARE FOR YOUNG BREAST CANCER PATIENTS: EXPLORING THE
COMFORT LEVEL AND SELF-ASSESSED COMPETENCY OF THE INTERPROFESSIONAL
HEALTH CARE TEAM
1
2
2
Merrylee McGuffin , Lynn Tathanhlong , Bonnie Bristow
1
Sunnybrook Health Sciences Centre, Toronto, ON
2
University of Toronto, Toronto, ON
119
TEAM-BASED CLINICAL SIMULATION IN RADIATION MEDICINE: VALUE TO ATTITUDES
AND PERCEPTIONS OF INTERPROFESSIONAL COLLABORATION
1
1
2
1
2
1
Caitlin Gillan , Meredith Giuliani , Olive Wong , Nicole Harnett , Emily Milne , Douglas Moseley ,
1
1
1
Robert Thompson , Pamela Catton , Jean-Pierre Bissonnette
1
University of Toronto, Toronto, ON
2
Princess Margaret Cancer Centre, Toronto, ON
120
ADDRESSING THE NEED FOR IMPROVEMENTS IN PATIENT SAFETY THROUGH
COLLABORATIVE EDUCATION AT THE NOVA SCOTIA CANCER CENTRE
1
2
2
2
2
Lisa Bourne , Helmut Hollenhorst , Nikhilesh Patil , Dorianne Rheaume , Robert Rutledge ,
1
1
1
1
1
Raymond Wright , Cheryl Anderson , Adam Burgess , Adam Crossman , Leslie Blair , Mammo
2
1
Yewonndwossen , Kathryn Moran
1
Capital District Health Authority, Halifax, NS
2
Dalhousie University, Halifax, NS
121
INTERDISCIPLINARY DIDACTIC INSTRUCTION FOR MEDICAL PHYSICS AND RADIATION
ONCOLOGY RESIDENTS
1
2
1
1
Heather Warkentin , C. Suzanne Drodge , Geetha Menon , Sherry Connors
1
University of Alberta, Edmonton, AB
2
Cross Cancer Institute, Edmonton, AB
122
CONCORDANCE OF A CLINICAL SPECIALIST RADIATION THERAPIST AND RADIATION
ONCOLOGIST: A PROSPECTIVE STUDY INVOLVING TREATMENT PLANNING AND
ASSESSMENT OF PATIENTS RECEIVING PALLIATIVE RADIOTHERAPY FOR BONE
METASTASES
1
1
1
1
1
Natalie Rozanec , Charles Cho , Louis Fenkell , Zahra Kassam , Mojgan Taremi , Zishan
1
1
1
2
3
Allibhai , Jason Wong , Woodrow Wells , Laura Zychla , Nicole Harnett
1
The Stronach Regional Cancer Centre, Newmarket, ON
2
Cancer Care Ontario, Juravinski Cancer Centre, Toronto, ON
3
Cancer Care Ontario, Toronto, ON
123
PERCEPTIONS OF RECEPTIVITY: EXPLORING TOBACCO USE AND SMOKING CESSATION
BEST PRACTICES FROM THE PERSPECTIVES OF INDIVIDUALS WITH LUNG CANCER AND
HEALTH CARE PROFESSIONALS: FINDINGS FROM PHASE 1
Bonnie Bristow, Arlene Court, Elaine Curle, Leslie Gibson, Margaret Fitch, Andrea Eisen, Lisa
Di Prospero
Odette Cancer Centre, Toronto, ON
27
124
ASSESSING THE PSYCHOLOGICAL IMPACT OF DAILY BOWEL PREPARATION ON
PROSTATE PATIENTS WHO RECEIVE RADIATION THERAPY
Bonnie Bristow, Laura D'Alimonte, Merrylee McGuffin, Ewa Szumacher, Margaret Fitch, Lisa Di
Prospero
Odette Cancer Centre, Toronto, ON
125
EVALUATION OF HIGH-FIDELITY SIMULATION TRAINING IN RADIATION ONCOLOGY
Meredith Giuliani, Caitlin Gillan, Olive Wong, Nicole Harnett, Emily Milne, Douglas Moseley,
Robert Thompson, Pamela Catton, Jean-Pierre Bissonnette
Princess Margaret Cancer Centre, Toronto, ON
126
THE ROLE OF THE GLOBAL RADIATION ONCOLOGY ELECTIVE IN TEACHING CANMEDS
COMPETENCIES
1
2
3
3
Kara Schnarr , Jean-Marc Bourque , Ian Dayes , Joda S. Kuk
1
McMaster University, Hamilton, ON
2
Western University, London, ON
3
McMaster University, Hamilton, ON
127
RADIOTHERAPY-INDUCED CASTRATION IN MEN WITH ADVANCED PROSTATE CANCER.
RESULTS OF A PROSPECTIVE PHASE I STUDY
1
1
2
2
Sergio Faria , Fabio Cury , Marie Duclos , Luis Souhami
1
McGill University, Montreal, QC
2
McGill University Health Centre, Montreal, QC
128
YM155, A NOVEL SMALL-MOLECULE SURVIVIN SUPPRESSANT, COMBINED WITH
RADIATION THERAPY IN PROSTATE CANCER CELL LINES
John Thoms, Satoko Aoki, Youlian Tzenov
Memorial University of Newfoundland, St. John's, NL
129
DEVELOPMENT OF A NEW FORMULA FOR THE DETERMINATION OF THE GLOMERULAR
FILTRATION RATE IN PATIENTS WITH HEAD AND NECK CANCER
Edwin Boelke, Christiane Matuschek, Gisela Schieren, Derik Hermsen, Maximillian Pelzer, Peter
Arne Gerber, Wilfried Budach
Heinrich Heine University, Dusseldorf, Germany
130
THE PARADOX OF LIVER STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR):
APPROACHING MAXIMUM ORGAN TOLERANCE AFTER ONLY ONE TREATMENT
Marc-Emile Plourde, Janice Doody, Robert MacRae, Jason R. Pantarotto
Ottawa Hospital Cancer Program, Ottawa, ON
131
EFFECT OF STEREOTACTIC BODY RADIOTHERAPY FOR LIVER CANCER ON QUALITY OF
LIFE
Jonathan Klein, Laura Dawson, Haiyan Jiang, John Kim, Rob Dinniwell, Jim Brierley, Rebecca
Wong, Gina Lockwood, Jolie Ringash
Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
132
MANAGEMENT AND OUTCOMES OF ELDERLY PATIENTS TREATED FOR CANCER OF
ESOPHAGUS
Melody Xuan Lu Qu, Alexander Banashkevich, Aamer Mahmud
28
Cancer Centre of Southeastern Ontario, Kingston, ON
133
THE USE OF FLUOROSCOPY ON THE TRUEBEAM LINEAR ACCELERATOR AS A MEANS
TO IDENTIFY STEREOTACTIC ABLATIVE LIVER PATIENTS SUITABLE FOR RESPIRATORY
GATED TREATMENT
1
1
1
1
1
Devin Schellenberg , Weber Britta , Moira Pearson , Marie-Laure Camborde , Mohamed Khan ,
1
1
2
1
1
Richard Lee , Emily Vollans , Shaun Loewen , Cheryl Duzenli , Roy Ma
1
British Columbia Cancer Agency, Vancouver, BC
2
Cancer Care Manitoba, Winnipeg, MB
134
VARIATION IN PRACTICE - A NEED FOR REGULAR INSTITUTIONAL REVIEWS AND
PARTICIPATION IN CLINICAL TRIALS
1
2
Pierre-Yves McLaughlin , Aamer Mahmud
1
Queen's University, Kingston, ON
2
Cancer Centre of Southeastern Ontario, Kingston, ON
135
EFFECTS OF AGING ON LONG TERM ERECTILE FUNCTION FOLLOWING LDR PROSTATE
BRACHYTHERAPY
Mira Keyes
British Columbia Cancer Agency, Vancouver, BC
136
LONG-TERM RESULTS OF A RANDOMIZED TRIAL COMPARING IRIDIUM IMPLANT PLUS
EXTERNAL-BEAM RADIATION THERAPY WITH EXTERNAL-BEAM RADIATION THERAPY
ALONE IN NODE-NEGATIVE LOCALLY ADVANCED CANCER OF THE PROSTATE.
1
2
1
2
1
1
3
Ian Dayes , Sameer Parpia , Jackie Gilbert , Jim Julian , Ian Davis , Mark Levine , Jinka Sathya
1
McMaster University, Hamilton, ON
2
Ontario Clinical Oncology Group, Hamilton, ON
3
Memorial University, St. John's, NL
137
STEREOTACTIC ABLATIVE RADIOTHERAPY VERSUS LOW DOSE RATE
BRACHYTHERAPY: A PROPENSITY MATCHED ANALYSIS OF CANADIAN DATA
1
2
2
3
3
Andrew Loblaw , Tom Pickles , Juanita Crook , Andre-Guy Martin , Eric Vigneault , Charles
1
1
4
5
5
Catton , Patrick Cheung , Perakaa Sethukavalan , Andrew Warner , Ying Yang , George
5
Rodrigues
1
University of Toronto, Toronto, ON
2
University of British Columbia, Vancouver, BC
3
L’Université Laval, Quebec City, QC
4
Odette Cancer Centre, Toronto, ON
5
University of Western Ontario, London, ON
138
PSA BOUNCE AFTER STANDARD FRACTIONATION OF HYPOFRATIONATED EXTERNAL
RADIOTHERAPY AND BRACHYTHERAPY: AN INVESTIGATION OF ITS ETIOLOGY AND
COMPARISON OF ITS OCCURRENCE
Alexandra Waters, Guila Delouya, David Donath, Carole Lambert, Sandra Larrivée, Daniel
Taussky
Université de Montréal, Montreal, QC
139
PROGNOSTIC FACTORS FOR PROSTATE CANCER ENDPOINTS FOLLOWING
BIOCHEMICAL FAILURE: A SYSTEMATIC REVIEW OF THE LITERATURE
Timothy Nguyen, George Rodrigues, Gabriel Boldt
University of Western Ontario, London, ON
29
140
IMPACT OF IMAGE REGISTRATION SURROGATES ON THE PTV GEOMETRY FOR
BLADDER RADIOTHERAPY
Vickie Kong, Tara Rosewall, Tim Craig, Michael Milosevic, Robert Bristow, Susan Chan, Peter
Chung
University of Toronto, Toronto, ON
141
LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONIST FOR PATIENTS WITH
PROSTATE CANCER
1
1
1
1
2
3
Patricia Tai , Arbind Dubey , Evgeny Sadikov , Asim Amjad , Rashmi Koul , Kurian Joseph , Avi
4
5
6
Assouline , Siu-Kie Au , Edward Yu
1
Allan Blair Cancer Centre, Regina, SK
2
Manitoba Cancer Foundation, Winnipeg, MB
3
Cross Cancer Centre, Edmonton, AB
4
de la Porte de Saint Cloud, Paris, France
5
Queen Elizabeth Hospital, Hong Kong, China
6
London Regional Cancer Progam, London, ON
142
PROSTATE VOLUME DOWNSIZING WITH DEGARELIX PRIOR TO BRACHYTHERAPY
Jim Rose, Brent Parker, Ana Fernandez-Ots, Miren Gaztanaga, Francois Bachand, David Petrik,
Juanita Crook
British Columbia Cancer Agency, Kelowna, BC
143
ROBOTIC MANIPULATOR USING SOFT PNEUMATIC AIR-MUSCLES ACTUATOR FOR
NEEDLE GUIDANCE AND FIDUCIAL MARKER INSERTION IN A PHANTOM UNDER REALTIME DIRECT MRI GUIDANCE: A PROOF OF CONCEPT
1
2
2
2
André-Guy Martin , Genevieve Miron , Catherine Veronneau , Francis Therien , David
3
3
Bouchard , Jean-Sebastien Plante
1
Centre Hospitalier Universitaire de Québec - L'Hôtel-Dieu de Québec, Québec, QC
2
Université de Sherbrooke, Sherbrooke, QC
3
Polymer Robotics Inc., Sherbrooke, QC
144
LONG-TERM SURVIVAL IN A PATIENT WITH METASTATIC SPINAL CORD COMPRESSION
FROM A PROSTATE CANCER WITH ULTRA-HIGH PSA: CASE REPORT AND REVIEW OF
THE LITERATURE
Nhu-Tram Nguyen, Sebastien Hotte, Ian Dayes
Juravinski Cancer Centre, Hamilton, ON
145
GENETIC POLYMORPHISMS ASSOCIATED WITH RADIATION-RELATED ESOPHAGITIS
AND PNEUMONITIS FOLLOWING DEFINITIVE TREATMENT FOR NON-SMALL CELL LUNG
CANCER (NSCLC)
1
1
2
1
1
1
Kate Barrett , Jingxiong Xu , Su Woon Kim , Kevin Boyd , Dangxiao Cheng , Zhuo Chen ,
1
1
1
1
1
1
Andrea Bezjak , Alex Sun , John Cho , Anthony Brade , Natasha Leighl , Frances Shepherd ,
1
1
1
Wei Xu , Geoffrey Liu , Andrew Hope
1
University of Toronto, Toronto, ON, Canada
2
National Cancer Centre Singapore, Singapore, China
146
UTERINE SARCOMA: CLINICO-EPIDIOLOGICAL AND PATHOLOGICAL CHARACTERISTICS
AND COMBINED TREATMENT MODALITIS OUTCOME: A SINGLE INSTITUTION
RETROSPECTIVE ANALYSIS FROM SAUDI ARABIA
30
1
1
2
1
1
Khalid H.Sait , Nisreen Affinan , Mohamed Ezzat El Sayed , Shadi Al khayat , Ahmed Ghanem ,
1
1
Reem Abayazid , Hesham Sait
1
King Abdulaziz University, Jeddah, Saudi Arabia
2
King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia
147
PELVIC AND PARA-AORTIC EXTENTED FIELD RADIOTHERAPY FOR ADVANCED STAGE
UTERINE CANCER: DOSIMETRIC AND TOXICITY COMPARISON BETEWEEN 4-FIELD BOX
AND IMRT
Boris Bahoric, Alexander Rabinovich, Laurence Bernard, Walter Gotlieb
Jewish General Hospital, McGill University, Montreal, QC
148
OUTCOMES FOLLOWING RADIOTHERAPY IN N3 HEAD AND NECK CANCER STRATIFIED
BY HPV STATUS
Eric Tran, Shao Hui Huang, John Waldron, Xiaowei Shen, Wei Xu, Eugene Yu, John De Almeida,
Albiruni Razak, David Goldstein, Bayardo Perez-Ordonez, Ilan Weinreb, Brian O'Sullivan
Princess Margaret Cancer Centre, Toronto, ON
149
PREDICTING OUTCOMES FOR OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
(OPSCC) IN THE HUMAN PAPILLOMAVIRUS (HPV) ERA: IS RADIOTHERAPY ALONE
SUFFICIENT TREATMENT FOR HPV-POSITIVE TUMOURS?
Stacey Yemchuk, Sandeep Dhaliwal, Anthony Nichols, John Yoo, Nancy Read, Kevin Fung,
Varagur Venkatesan, Alex Hammond, Andrew Warner, John Barrett, David Palma
University of Western Ontario, London, ON, Canada
150
SURVIVAL PREDICTOR IN OROPHARYNGEAL CANCER PATIENTS WITH DISTANT
METASTASIS
Shao Hui Huang, John Waldron, Wei Xu, Li Tong, Jolie Ringash, Andrew Bayley, Andrew Hope,
John Kim, John Cho, Meredith Giuliani, Bayardo Perez-Ordonez, Ilan Weinreb, Eric Chen, David
Goldstein, Brian O'Sullivan
Princess Margaret Cancer Centre, Toronto, ON
151
PATIENT REPORTED OUTCOMES: CORRELATION OF MDASI-HN AND CLINICAL SUPPORT
REQUIRED FOR PATIENTS RECEIVING CURATIVE HEAD AND NECK
CHEMORADIOTHERAPY
Matthew Mason, Meredith Giuliani, Melanie Rose, Jennifer Deering, Shao Hui Huang, Haiyan
Jiang, Brian O'Sullivan, Andrew Bayley, Jolie Ringash, John Cho, John Kim, John Waldron,
Andrew Hope University of Toronto, Toronto, ON
152
ELDERLY PATIENTS WITH ADVANCED HEAD AND NECK CANCER LESS LIKELY TO
RECEIVE RADIATION THERAPY
1
2
1
1
1
1
Meredith Giuliani , Heather Baer , Brian O'Sullivan , Lisa W. Le , Pamela Catton , Andrew Hope ,
1
1
Shabbir Alibhai , David Hodgson
1
Princess Margaret Cancer Centre, Toronto, ON
2
Harvard University, Boston, MA
153
HEAD AND NECK SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY: IS THERE A
BETTER TREATMENT?
1
2
1
1
1
Nhu-Tram Nguyen , Han Zhang , D. Ian Hodson , Lilian Doerwald-Munoz , Jim Wright
1
Juravinski Cancer Centre, Hamilton, ON
2
University of Alberta, Edmonton, AB
31
154
A PROSPECTIVE STUDY OF TOXICITY PROFILING IN PATIENTS WITH SQUAMOUS CELL
CARCINOMA OF THE HEAD AND NECK (SCCHN) TREATED WITH HELICAL
TOMOTHERAPY INTENSITY MODULATED RADIOTHERAPY (HTIMRT), FIVE-YEAR
RESULTS
Mohammed Y. Almaghrabi, Samy El-Sayed, Horia Marginean, Ionut Busca, Bernd Esche
University of Ottawa, Ottawa, ON
155
OUTCOMES FOLLOWING RE-IRRADIATION FOR RECURRENT NASOPHARYNGEAL
CARCINOMA AT A CANADIAN CANCER CENTRE
Irene Karam, Shao Hui Huang, Andrea McNiven, Susie Su, Wei Xu, John Waldron, Andrew J.
Bayley, John Kim, John Cho, Jolie Ringash, Andrew Hope, Brian O'Sullivan, Meredith Giuliani
Princess Margaret Cancer Centre, Toronto, ON
156
ROLE OF RADIOTHERAPY IN MANAGEMENT OF NASAL AND SINONASAL SQUAMOUS
CELL CARCINOMA
Issa Mohamad, Shao Hui Huang, Susie Su, Wei Xu, Andrew Bayley, John Kim, John Cho, Jolie
Ringash, Andrew Hope, Meredith Giuliani, Albiruni Razak, Ian Witterick, Brian O'Sullivan, John
Waldron
Princess Margaret Cancer Centre, Toronto, ON
157
GUIDELINES FOR SELECTION OF CLINICAL TARGET VOLUME IN HEAD AND NECK
SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY SITE
Ali Hosni, Shao Hui Huang, John De Almeida, Michael Au, Peter Dixon, Biu Chan, Susie Su, Wei
Xu, John Cho, Meredith Giuliani, Andrew Hope, Andrew J. Bayley, John Kim, Jolie Ringash, Brian
O’Sullivan, John Waldron
University of Toronto, Toronto, ON
158
SINGLE INSTITUTION EXPERIENCE OF OUTCOMES OF HEAD AND NECK TUMOURS
TREATED WITH STEREOTACTIC BODY RADIOTHERAPY (SBRT)
Luluel Khan, Hamid Raziee, Justin Lee, Ian Poon
University of Toronto, Toronto, ON
159
A PROSPECTIVE STUDY OF LOCAL CONTROL (LC), PATTERN OF FAILURE (PF) AND
SURVIVAL (OS) IN PATIENTS WITH SQUAMOUS CARCINOMA OF THE HEAD AND NECK
REGION (SCCHN) TREATED WITH IMRT RADIOTHERAPY, RESULTS OF FIVE-YEAR
FOLLOW UP
1
1
1
1
Mohammed Y. Almaghrabi , Samy El-Sayed , Horia Marginean , Ionut Busca , Hussain Al2
Hussain
1
University of Ottawa, Ottawa, ON
2
King Fahad Medical City, Riyadh, Saudi Arabia
160
ROLE OF FDG-PET-CT IN SCREENING FOR SYNCHRONOUS CANCER IN PATIENTS WITH
HEAD AND NECK MALIGNANCIES
Nikhilesh Patil, Carol-Ann Davis, Allan Day, Christopher Thomas, Murali Rajaraman, Helmut
Hollenhorst, Derek Wilke
Nova Scotia Cancer Centre, Halifax, NS
161
EARLY RESULTS OF IMPLEMENTATION OF IMRT FOR LOCALLY ADVANCED HEAD AND
NECK CANCER IN A PERIPHERAL CENTRE
32
Marc Gaudet, Alain Haddad, Annie Doiron, Marylene Brodeur
CSSS de Gatineau, Gatineau, QC
162
HEAD AND NECK CANCER OUTCOME IN WINDSOR ONTARIO: A BORDER CITY SINGLE
INSTITUTION EXPERIENCE
1
1
1
2
1
1
Ming Pan , Ken Schneider , Swati Kulkarni , Daphne Southcott , Yasmin Alam , Pamathy Vivek ,
Rasna Gupta1, Akmal Ghafoor1, John Mathews1, Tarek Elfiki1, Sindu Mary Kanjeekal1, Khalid
1
1
1
1
Hirmiz1, Junaid Yousuf , Colvin Springer , Youyi Le , Caroline Hamm
1
Windsor Regional Hospital Cancer Centre, Windsor, ON
2
University College Dublin, Dublin, Ireland
163
STEREOTACTIC BODY RADIOTHERAPY FOR LUNG METASTASES: A SINGLE INSTITUTION
EXPERIENCE
Qurrat Mehmood, Andrew Hope, Thomas Waddell, Marcello Cypel, John Cho, Lisa Le, Anthony
Brade, Alex Sun, Mojgan Taremi, Andrea Bezjak, Meredith Giuliani
Princess Margaret Cancer Centre, Toronto, ON
164
A RISK-ADAPTED APPROACH TO POST-OPERATIVE RADIOTHERAPY FOR THYMOMA:
LONG-TERM OUTCOMES AND PREDICTORS OF RECURRENCE
Nafisha Lalani, Najib Safieddine, David Hwang, Shaf Keshavjee, Andrea Bezjak, Anthony Brade
University of Toronto, Toronto, ON
165
IS INTERMEDIATE RADIATION DOSE ESCALATION WITH CONCURRENT CHEMOTHERAPY
FOR STAGE III NON-SMALL CELL LUNG CANCER BENEFICIAL? A MULTI-INSTITUTIONAL
PROPENSITY-SCORE MATCHED ANALYSIS
1
2
3
4
2
George Rodrigues , Suresh Senan , Cary Oberije , Kayoko Tsujino , Terry Wiersma , Marta
5
6
7
8
9
Moreno-Jimenez , Tae Hyun Kim , Lawrence Marks , Ramesh Rengan , Luigi De Petris , Sara
10
11
12
1
13
Ramella , Kim De Ruyck , Nuria Rodrigues de Dios , Andrew Warner , Jeffrey Bradley , David
1
Palma
1
University of Western Ontario, London, ON
2
VU Amsterdam University, Amsterdam, Netherlands
3
Maastricht University Medical Centre, Maastrict, Netherlands
4
Hyogo Cancer Center, Hyogo, Japan
5
University of Navarra, Pamplona, Spain
6
Center for Proton Therapy, Goyang, Korea
7
University of North Carolina, Chapel Hill, NC
8
University of Washington, Seattle, WA
9
Karolinska University Hospital Solna, Stockholm, Sweden
10
Campus Bio-Medico University, Rome, Italy
11
Ghent University, Ghent, Belgium
12
Universidad Pompeu Fabra, Barcelona, Spain
13
Washington School of Medicine, St Louis, MO
166
LOCAL TREATMENT IMPROVES SURVIVAL IN NSCLC PATIENTS WITH SYNCHRONOUS
OLIGOMETASTASES
1
2
2
2
2
Gordon Guo , Pascal Lambert , Naseer Ahmed , Garry Schroeder , Harvey Quon , Derek
2
2
Fewer , Shaun K. Loewen
1
Cancercare Manitoba, Winnipeg, MB
2
University of Manitoba, Winnipeg, MB
167
CANADIAN LUNG STEREOTACTIC RADIOTHERAPY PRACTICES: SURVEY RESULTS
C. Suzanne Drodge, Lindsay Rowe, Alex Boychak, Sunita Ghosh, Zsolt Gabos
33
University of Alberta, Edmonton, AB
168
ACCELERATED HYPOFRACTIONATION VERSUS STEREOTACTIC ABLATIVE
RADIOTHERAPY (SABR) FOR EARLY-STAGE NON-SMALL CELL LUNG CANCER: RESULTS
OF A PROPENSITY SCORE-MATCHED ANALYSIS
1
1
2
2
2
Andrew Chiang , Isabelle Thibault , George Rodrigues , David Palma , Andrew Warner , Ian
1
1
3
1
Poon , Hany Soliman , Suneil Jain , Patrick Cheung
1
University of Toronto, Toronto, ON
2
University of Western Ontario, London, ON
3
Queen's University, Belfast, Ireland
169
RELATIONSHIP BETWEEN SUV (MAX) AND MAXIMUM TUMOUR DIMENSION ON DISEASEFREE AND OVERALL SURVIVAL IN LUNG CANCER PATIENTS TREATED WITH
STEROTACTIC BODY RADIOTHERAPY
1
1
1
1
1
1
Maryam Dosani , Ruobing Yang , Annie Houle , Don Wilson , Mitchell Liu , Hannah Carolan ,
2
2
Chad R. Lund , Devin Schellenberg
1
British Columbia Cancer Agency, Vancouver Centre, Vancouver, BC
2
British Columbia Cancer Agency, Fraser Valley Centre, Surrey, BC
170
CAN DOSE-VOLUME CONSTRAINTS PREDICT FOR RIB FRACTURE AFTER LUNG
STEREOTACTIC ABLATIVE BODY RADIOTHERAPY (SABR)?
1
1
1
1
1
1
Isabelle Thibault , Andrew Chiang , Darby Erler , Latifa Yeung , Ian Poon , Anthony Kim , Brian
1
1
2
1
1
Keller , Fiona Lochray , Suneil Jain , Hany Soliman , Patrick Cheung
1
University of Toronto, Toronto, ON
2
Queen's University Belfast, Belfast, United Kingdom
171
LATERAL ELECTRON DISEQUILIBRIUM (LED) IN LUNG CANCER PATIENTS TREATED
WITH STEREOTACTIC BODY RADIATION THERAPY: ASSESSING THE POTENTIAL FOR
UNDERDOSING
1
2
1
1
Brandon Disher , Laura Wade , George Hajdok , Stewart Gaede , Jerry J. Battista1, David
1
Palma
1
London Regional Cancer Program, London, ON
2
University of Western Ontario, London, ON
172
ADAPTIVE DOSE-ESCALATION USING SERIAL 4D-PET/CT SCANS DURING
RADIOTHERAPY FOR LOCALLY-ADVANCED NON SMALL CELL LUNG CANCER
1
1
1
1
1
2
Mei Ling Yap , Alexander Sun , Jane Higgins , Andrea Marshall , Nathan Becker , Lisa Le , Katy
1
1
1
1
Clarke , Douglass Vines , Andrea Bezjak , Jean-Pierre Bissonnette
1
University of Toronto, Toronto, ON
2
Princess Margaret Cancer Centre, Toronto, ON
173
PALLIATIVE RADIOTHERAPY FOR MERKEL CELL CARCINOMA
Elizabeth Barnes, Luluel Khan, Judith Balogh, May Tsao, Justin Lee, Stanley Liu, Gregory
Czarnota,
Emily Sinclair
Odette Cancer Centre, Toronto, ON
174
ROLE OF THE 53BP1-APLF INTERACTION IN THE DNA DAMAGE RESPONSE
1
1
2
Diana Tran , Amanda Fenton , Christine Koch
1
University of Toronto, Toronto, ON
2
Princess Margaret Cancer Centre, Toronto, ON
34
175
CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICES (CIED) IN PATIENTS
RECEIVING RADIOTHERAPY; VALIDATION OF THE CANCER CENTER OF SOUTH
EASTERN ONTARIO AT KINGSTON GENERAL HOSPITAL’S CIED MONITORING PROTOCOL
Kadir Mullings, Michael Brundage, Damian Redfearn, Jane Caldwell, Catherine de Metz, Debra
Campbell
Queens University, Kingston, ON
176
OUTCOMES FOLLOWING RESUSCITATION FOR CARDIO-RESPIRATORY ARRESTS
SPECIFIC TO ONCOLOGY IN-PATIENTS
1
1
1
1
2
Vivian Yau , Susan Robinson , Normand Laperriere , Michael Christian , Cynthia Harris , Neesha
1
1
1
Dhani , Mary Gospodarowicz , Arjun Sahgal
1
University of Toronto, Toronto, ON
2
Mount Sinai Hospital, Toronto, ON
177
PALLIATIVE RADIOTHERAPY FOR BONE METASTASES: POPULATION-BASED
UTILIZATION NEAR END OF LIFE IN A CANADIAN PROVINCE
1
1
1
1
2
Manpreet Singh Tiwana , Mark Barnes , Andrew Kiraly , Stacy Miller , David Hoegler , Ivo
3
1
Olivotto , Robert A. Olson
1
British Columbia Cancer Agency, Centre for the North, Prince George, BC
2
British Columbia Cancer Agency, Centre for the Southern Interior, Kelowna, BC
3
British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, BC
178
RADIOTHERAPY FRACTIONATION SCHEDULES PRESCRIBED ARE DEPENDENT ON THE
DISTANCE A PATIENT TRAVELS TO RECEIVE TREATMENT
1
1
1
2
3
1
Mark Barnes , Manpreet Tiwana , Stacy Miller , Ivo Olivotto , Andrew Kiraly , Rob Olson
1
British Columbia Cancer Agency, Centre for the North, Prince George, BC
2
British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, BC
3
University of Northern British Columbia, Prince George, BC
179
IMPACT OF PROPHYLACTIC DEXAMETHASONE ON PAIN FLARE FOLLOWING SPINE
STEREOTACTIC BODY RADIOTHERAPY (SBRT)
Luluel Khan, Andrew Chiang, Lying Zhang, Fiona Lochray, Isabelle Thibault, Gillian Bedard, Erin
Wong, Andrew Loblaw, Hany Soliman, Edward Chow, Arjun Sahgal
University of Toronto, Toronto, ON
180
PROSPECTIVE ANALYSIS OF PATIENT REPORTED SYMPTOMS AND QUALITY OF LIFE IN
PATIENTS WITH INCURABLE LUNG CANCER TREATED IN A RAPID ACCESS CLINIC
1
2
1
3
1
1
Shilo Lefresne , Robert Olson , Rosemary Cashman , Will Jiang , Paula Kostuik , Karen Levy ,
1
1
1
1
Mitchell Liu , Hannah Carolan , Michael McKenzie , Eric Berthelet
1
British Columbia Cancer Agency, Vancouver, BC
2
British Columbia Cancer Agency, Prince George, BC
3
University of British Columbia, Vancouver, BC
181
HEMOSTATIC RADIOTHERAPY IN ADVANCED BLADDER CANCER: A SINGLE-INSTITUTION
REVIEW
Saif Aljabab, Peter Cheung, Dennis Kristopher, Scott Morgan
University of Ottawa, Ottawa, ON
182
35
QUALITY OF LIFE IN PATIENTS TREATED WITH STEREOTACTIC ABLATIVE BODY
RADIOTHERAPY (SABR) FOR LIVER METASTASES
Isabelle Thibault, William Chu, Kelvin Chan, Darby Erler, Edward Chow, Hans Chung
University of Toronto, Toronto, ON
183
A PROSPECTIVE PILOT STUDY OF NAUSEA AND VOMITING AMONG PATIENTS
RECEIVING NEOADJUVANT LONG-COURSE RADIATION THERAPY AND 5-FU-BASED
CHEMOTHERAPY FOR RECTAL ADENOCARCINOMA
1
2
2
3
2
Kristopher Dennis , Michael Poon , Jordan Stinson , Gemma Cramarossa , Liang Zeng , Carlo
2
2
2
2
2
De Angelis , Hans Chung , Natalie Coburn , C. Shun Wong , Edward Chow
1
University of Ottawa, Ottawa, ON
2
University of Toronto, Toronto, ON
3
Queen's University, Kingston, ON
184
INVESTIGATION THE USE OF ELECTRONIC TECHNOLOGIES (ECT) AS A MEANS TO
EVALUATE TREATMENT OUTCOME FOR PATIENTS COMPLETING PALLIATIVE
RADIOTHERAPY
Michelle Lau, Andrea Bezjak, Wilfred Levin, Nicole Harnett, Rebecca Wong
Princess Margaret Cancer Centre, Toronto, ON
185
THORACIC REIRRADIATION FOR LUNG CANCER: A LITERATURE REVIEW
C. Suzanne Drodge, Sunita Ghosh, Alysa Fairchild
University of Alberta, Edmonton, AB
186
PROGNOSTIC FACTORS PREDICTING NECESSITY FOR SURGERY IN PATIENTS WITH
MALIGNANT EPIDURAL SPINAL CORD COMPRESSION
Tatiana Conrad, Lisa Wang, Andrea Bezjak, Wilfred Levin, Laura A Dawson, Michael Fehlings,
Rebecca Wong, Raja Rampersaud
University of Toronto, Toronto, ON
187
A PROSPECTIVE PHASE II TRIAL OF PALLIATIVE RADIOTHERAPY WITH HELICAL
TOMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA
1
2
2
2
1
2
Rufus Scrimger , Sunita Ghosh , Colin Field , Anil Joy , Zsolt Gabos , Michael Smylie , Charles
2
2
Butts , Quincy Chu
1
Cross Cancer Institute, Edmonton, AB
2
University of Alberta, Edmonton, AB
188
TEN YEAR EXPERIENCE OF A RESEARCH STUDENT PROGRAM (2004-2013) - THE
ODETTE CANCER CENTRE RAPID RESPONSE RADIOTHERAPY PROGRAM EXPERIENCE
1
1
1
1
1
Cyril Danjoux , Natalie Pulenzas , Breanne Lechner , Gillian Bedard , Erin Wong , Rachel
1
1
1
1
1
2
McDonald , Lori Holden , May Tsao , Elizabeth Barnes , Ewa Szumacher , Gonenc Fenton ,
1
Edward Chow
1
Odette Cancer Centre, Toronto, ON
2
Waterloo University, Waterloo, ON
189
PALLIATIVE RADIOTHERAPY TO BONE AND BRAIN METASTASES IN THE MIDDLE EAST
REGION: FIVE YEARS’ EXPERIENCE AT A TERTIARY CENTER IN IRAQ
1
1
1
1
2
Layth Mula-Hussain , Karzan Marif , Shkar Othman , Nyan Othman , Zhian S. Ramzi , Laith A.
2
Alrudainy
1
Slemani Radiation Oncology Center, Sulaymaniyah, Iraq
2
University of Sulaymaniyah, Sulaymaniyah, Iraq
36
190
PEDIATRIC THYROID CANCER: NOT AS RARE AS YOU THINK! SO HOW SHOULD WE
TREAT THEM?
1
2
1
2
Susan Chafe , Clare McDonald , Sandy McEwan , Robert Couch
1
Cross Cancer Institute, Edmonton, AB
2
Stollery Children's Hospital, Edmonton, AB
191
OUTCOMES OF THYROID CANCER IN CHILDREN: A 53-YEAR REVIEW
1
2
2
1
3
Susan Chafe , Clare McDonald , Robert Couch , Sandy McEwan , Jennifer Chafe
1
Cross Cancer Institute, Edmonton, AB
2
Stollery Children's Hospital, Edmonton, AB
3
University of Alberta, Edmonton, AB
192
THE OUTCOMES OF RADIOTHERAPY AND SURGERY FOR BLADDER CANCER: A
POPULATION-BASED OUTCOMES STUDY
Mackillop William, Robert Siemens, Khaled Zaza, Gavin Li, Yingwei Peng, Weidong Kong, David
Berman,
Christopher Booth
Queen's University, Kingston, ON
193
PRIORITY SETTING AND RESOURCE ALLOCATION FOR CANCER TREATMENTS IN CAPE
BRETON: WHICH TECHNOLOGIES SHOULD WE INVEST IN?
Waseem Sharieff
Dalhousie University, Sydney, NS
194
DIVERSITY BASED ON GENDER, COUNTRY OF ORIGIN, ETHNICITY, AND AGE OF THE
CANADIAN RADIATION ONCOLOGY PHYSICIAN WORKFORCE
1
2
Gaurav Bahl , Mihir Gupta
1
British Columbia Cancer Agency, Abbotsford, BC
2
Royal College of Surgeons Ireland, Dublin, Ireland
195
®
THE CHOOSING WISELY CANADA CANCER INITIATIVE
1
2
3
2
4
5
Gunita Mitera , Andrea Bezjak , Guila Delouya , Craig Earle , Kara Laing , Marianne Taylor ,
6
7
1
1
1
Steven Latosinsky , Christine Desbiens , Natasha Camuso , Mary Argent-Katwala , Geoff Porter
1
Canadian Partnership Against Cancer, Toronto, ON
2
University of Toronto, Toronto, ON
3
L'Université de Montréal, Montreal, QC
4
Memorial University of Newfoundland, St. John's, NL
5
University of British Columbia, Vancouver, BC
6
University of Western Ontario, London, ON
7
Université Laval, Quebec City, QC
196
CANCER SCREENING IPHONE APPLICATION
Moein Alizadeh, Houda Bahig, Jean-Paul Bahary
Université de Montréal, Montreal, QC
197
INITIAL RESULTS OF IMPLEMENTING AN ONCOLOGY INFORMATION SYSTEM TO
SUPPORT AN INTEGRATED CARE MODEL OF A NEW AMBULATORY CANCER CENTRE
1
2
Marie-Andrée Fortin , Fred Ashbury
1
CSSSL, Laval, QC
37
2
University of Toronto, Toronto, ON
198
4D CONE BEAM COMPUTED TOMOGRAPHY FOR TARGET LOCALIZATION IN
STEREOTACTIC BODY RADIOTHERAPY FOR EARLY LUNG CANCER
1
2
2
2
2
2
Daniel Glick , Tania Karan , Ken Le , Zishan Allibhai , Mojgan Taremi , Douglas Moseley
1
University of Toronto, Toronto, ON
2
Stronach Regional Cancer Centre, Newmarket, ON
199
THE CLINICAL APPLICATION OF USING GAFCHROMIC EBT3 FILM FOR QUALITY
ASSURANCE IN CUTANEOUS RADIATION THERAPY
1
1
1
1
2
James Gräfe , Rao Khan , Eduardo Villarreal-Barajas , Peter Dunscombe , Hongwei Liu
1
University of Calgary, Calgary, AB
2
University of Alberta, Red Deer, AB
200
PATIENT SET-UP REPRODUCIBILITY WHEN TREATING THE INGUINAL AND FEMORAL
LYMPH NODES: A COMPARISON OF TWO IMMOBILIZATION SYSTEMS
Kevin Smith, Julia Culhane, Joe Micallef, Ivan Yeung, Elen Moyo, Ahmar Abbas
Stronach Regional Cancer Centre at Southlake, Newmarket, ON
201
TRIALS AND TRIBULATIONS OF CREATING A PAPERLESS RADIATION THERAPY WORK
PLACE: THE NOVA SCOTIA EXPERIENCE
Jim Clancey, Peilong Zhang, Murali Rajaraman, Jodie Trembley, Carol-Ann Davis, Angela
Whynot, Lisa Bourne, Christopher Thomas, Helmut Hollenhorst, Nikhilesh Patil
Dalhousie University, Halifax, NS
202
MULTICENTRE AND MULTIDISCPLINARY COLLABORATION ACROSS ATLANTIC
CANADIAN RADIOTHERAPY CENTRES
Paul Jugpal, Carol-Anne Davis, Rob Rutledge, Murali Rajaraman, Helmut Hollenhorst, Amanda
Cassie
Dalhousie University, Halifax, NS
203
INVESTIGATING THE IMPACT OF PET-CT VERSUS CT-ALONE FOR HIGH-RISK VOLUME
SELECTION IN HEAD & NECK AND LUNG PATIENTS UNDERGOING RADIOTHERAPY
Carol-Anne Davis, Mohamed Abdolell, Christopher Thomas, Allan Day, Helmut Hollenhorst,
Murali Rajaraman, Liam Mulroy, David Bowes, Slawa Cwajna, Nikhilesh Patil, Dorianne
Rheaume, Steven Burrell, Derek Wilke
Dalhousie University, Halifax, NS
204
FUNCTIONAL LUNG AVOIDANCE USING VENTILATION SPECT IN THE TREATMENT OF
ADVANCED-STAGE CARCINOMA OF THE LUNG: A TREATMENT PLANNING AND
FEASIBILITY STUDY
1
1
2
Jelena Lukovic , Brian Yaremko , Robin Reid
1
London Regional Cancer Program, London, ON
2
University of Western Ontario, London, ON
205
USE OF CT CISTERNOGRAMS IN TARGET DEFINITION FOR TRIGEMINAL NEURALGIA
RADIOSURGERY
Saif Althaqfi, John Sinclair, Santanu Chakraborty, Jean-Michel Caudrelier, Janos Szanto, Shawn
Malone
University of Ottawa, Ottawa, ON
38
206
VALIDATION OF A COMMONLY USED RADIATION TREATMENT PLANNING SOFTWARE
FOR DETERMINING PROGNOSTIC BODY COMPOSITION METRICS
Petra Grendarova, David Spencer, Corinne Doll, Robyn Banerjee
University of Calgary, Calgary, AB
207
ISSUES IN VOLUMETRIC MODULATED ARC THERAPY IN BREAST CANCER: A
DOSIMETRIC STUDY
Waseem Sharieff, Heping Xu
Dalhousie University, Sydney, NS
208
RADICAL CHEMO RADIOTHERAPY FOR ANAL CANAL CARCINOMA POST-RENAL
TRANSPLANT
Lucy Ward, Nikhilesh Patil, Slawa Cwajna
Dalhousie University, Halifax, NS
209
OUTCOMES AND TOXICITY OF STEREOTACTIC ABLATIVE RADIOTHERAPY FOR
CENTRAL LUNG TUMOURS: THE MAYO CLINIC EXPERIENCE
1
1
2
1
1
Benjamin Mou , Kenneth W. Merrell , Dawn A. Owen , Katy E. Nelson , Yolanda I. Garces ,
1
Kenneth R. Olivier
1
Mayo Clinic, Rochester, MN
2
Veterans Affairs Ann Arbor Health System, Ann Arbor, MI
210
OUTCOMES FROM FIRST THREE YEARS OF FRAMELESS STEREOTACTIC
RADIOSURGERY IN TREATING BRAIN METASTASES
Amandeep Taggar, Harold Lau, Gerald Lim, Robert Nordal, Rao Khan, Karen Breitman, Alana
Hudson, David Spencer, Jon-Paul Voroney
Tom Baker Cancer Centre, Calgary, AB
211
STEREOTACTIC ABLATIVE RADIOTHERAPY FOR GYNAECOLOGICAL MALIGNANCIES IN
THE OLIGOMETASTATIC SETTING
Joel Broomfield, Hal Hirte, Laurie Elit, Iwa Kong, Malti Patel, Sachi Voruganti, Charleen Smith,
Tom Chow, Anand Swaminath
Juravinski Cancer Centre, Hamilton, ON
212
SALVAGE SPINE STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR SPINAL
METASTASES THAT FAILED INITIAL SBRT: A FIRST REPORT
Isabelle Thibault, Mikki Campbell, Chia-Lin Tseng, Ameen Al-Omair, Fiona Lochray, Daniel
Letourneau, Eugene Yu, Young Lee, Michael Fehlings, Arjun Sahgal
University of Toronto, Toronto, ON
213
SPINE STEREOTACTIC BODY RADIOTHEARPY (SBRT) FOR OLIGOMETASTATIC
PATIENTS
1
2
2
2
2
Crystal Hann , Arjun Saghal , Eshety Atenafu , Daniel Letourneau , Eugene Yu , Normand
2
2
Laperriere , Michael Fehlings
1
McMaster University, Hamilton, ON
2
University of Toronto, Toronto, ON
214
WHEN IS A BIOPSY-PROVEN DIAGNOSIS NECESSARY BEFORE STEREOTACTIC
ABLATIVE RADIOTHERAPY FOR LUNG CANCER? A DECISION ANALYSIS
39
1
1
2
3
1
Alexander Louie , Suresh Senan , Pretesh Patel , Bart Ferket , Frank Lagerwaard , George
4
2
2
4
5
Rodrigues , Joseph Salama , Christopher Kelsey , David Palma , Myriam Hunink
1
VU University Medical Center, Amsterdam, Netherlands
2
Duke University Medical Center, Durham, NC
3
Harvard School of Public Health, Boston, MA
4
London Regional Cancer Program, London, ON
5
Harvard School of Public Health, Boston, MA
215
OUTCOMES WITH HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY (HFSRT) IN
PATIENTS WITH INTACT BRAIN METASTASES AND POST-OPERATIVE SURGICAL
CAVITIES
Luluel Khan, Hany Soliman, Wei Xu, Mark Ruschin, Nicolas Phan, Fiona Lochray, Julian Spears,
Sunit Das, Todd Mainprize, Arjun Sahgal
University of Toronto, Toronto, ON
216
ADJUVANT GAMMA-KNIFE RADIOSURGERY TO THE TUMOUR BED OF RESECTED
METASTASES: A SERIES OF 130 PATIENTS
Laurence Masson-Côté, Christian Iorio-Morin, Youssef Ezahr, Jocelyn Blanchard, Annie Ebacher,
David Mathieu
Unversité de Sherbrooke, Sherbrooke, QC
217
STEREOTACTIC RADIOSURGERY FOR REFRACTORY TRIGEMINAL NEURALGIA
1
1
2
2
1
Joel Broomfield , Anthony Whitton , Rocco DeVilliers , Thorsteinn Gunnarsson , Stephen Gauld ,
1
1
1
Chris DiFrancesco , Tom Chow , Jeffrey Greenspoon
1
Juravinski Cancer Centre, Hamilton, ON
2
McMaster University, Hamilton, ON
218
FACTORS INFLUENCING VERTEBRAL COMPRESSION FRACTURE SPECIFIC TO RENAL
CELL CARCINOMA SPINAL METASTASES AFTER STEREOTACTIC BODY RADIOTHERAPY:
A MULTI-INSTITUTIONAL STUDY
1
1
2
3
1
Isabelle Thibault , Eshetu Atenafu , Eric Chang , Sam Chao , Ameen Al-Omair , Nicholas
4
3
1
3
4
3
Boehling , Ehsan Balagamwala , Marcelo Cunha , Lilyana Angelov , Paul Brown , John Suh ,
4
1
1
Laurence Rhines , Michael Fehlings , Arjun Sahgal
1
University of Toronto, Toronto, ON
2
Department of Radiation Oncology, Los Angeles, CA
3
Cleveland Clinic, Cleveland, OH
4
MD Anderson Cancer Center, Houston, TX
219
STEREOTACTIC RADIOSURGERY FOR METASTASES IN ELOQUENT BRAIN AREAS
1
1
2
2
2
2
Fred Hsu , Para Kouhestani , Roy Ma , Michael McKenzie , Ermias Gete , Alan Nichol
1
British Columbia Cancer Agency, Abbotsford, BC
2
British Columbia Cancer Agency, Vancouver, BC
220
GAMMA KNIFE RADIOSURGERY FOR RECURRENT GLIOBLASTOMA MULTIFORME: A
SINGLE INSTITUTION EXPERIENCE
Laurence Masson-Côté, Annie Ebacher, Vincent Hubert-Tremblay, David Fortin, David Mathieu
Unversité de Sherbrooke, Sherbrooke, QC
221
FACTORS AFFECTING POST-OPERATIVE SURGICAL CAVITY VOLUME AND SURFACE
AREA DYNAMICS SPECIFIC TO BRAIN METASTASES
40
Yaser Hasan, Luluel Khan, Todd Mainprize, Sunit Das, Mark Ruschin, Fiona Lochray, Young Lee,
May Tsao, Arjun Sahgal, Hany Soliman
University of Toronto, Toronto, ON
222
DAILY HALF CONE BEAM COMPUTED TOMOGRAPHIES FOR LEFT-SIDED BREAST
CANCER: IS THE ADDED DOSE WORTH IT?
1
2
2
2
Nancy El-Bared , Etienne Létourneau , Eliane Plouffe , Dany Duplan
1
CHUM-Notre Dame Hospital, Montreal, QC
2
University of Montreal, Laval, QC
41